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Subthreshold symptoms of depression (defined as symptoms that do not meet full criteria 
for the disorder) are a significant concern, associated with a range of behavioral and emotional 
problems, raising the risk of adolescents developing more severe depression later. Yet research 
on subthreshold depression is lacking, and the relationship between affective and somatic 
symptom improvement has not been adequately studied. Prior research with adult samples lend 
credence to the hypothesis that symptoms of mood/motivation respond faster to psychotherapy 
(Rush, Beck, Kovacs, Weissenburger, &  Hollon, 1982)  than pharmacotherapy with the opposite 
response for vegetative symptoms such as sleep and appetite (DiMascio, Weissman, Prusoff, & 
Neu 1979). The current study was built upon prior research that found Interpersonal 
Psychotherapy Adolescent Skills Training (IPT-AST) to be an efficacious prevention 
intervention for adolescents with subthreshold depression, as compared to school counseling 
(Young, Mufson & Gallop, 2010).  In this investigation, we sought to compare the trends in 
symptomatic improvement among 32 participants treated with IPT-AST over eight weeks. 
Clusters of mood/ motivation and vegetative symptoms were followed from baseline to the end 
of treatment. The results suggest that mood symptoms improved significantly before vegetative 




vegetative symptoms was found to occur later between weeks 6 and 8. Thus adolescents 
receiving IPT-AST preventive treatment demonstrated faster reduction in mood/motivation 
symptoms than vegetative symptoms. Analyses revealed that fewer participants were identified 
as having not improved on the mood/motivation cluster than on the vegetative cluster indicating 
a better response for adolescents with mood symptoms than vegetative symptoms. Although, no 
relationships in improvements in mood/motivation and vegetative clusters were found 
controlling for baseline mood/motivation and vegetative symptoms; positive associations were 
found between cluster variables (mood, vegetative and total depression) over time. Gender was 
also not found to moderate the relationship between improvement on mood and vegetative 
symptoms over time indicating no significant differences in the improvement between males and 
females. Overall, findings from the current investigation strengthen the results from previous 
studies regarding the timeline of symptom improvement with IPT-AST. 
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Depression is one of the most commonly diagnosed psychiatric disorders among 
adolescents.  It can be conceptualized as a constellation of several symptoms which include 
physical, mood, motivation, cognitive and suicidal symptoms.  Depression is often characterized 
by angry or irritable mood, sadness or hopelessness, difficulties concentrating, social withdrawal, 
changes in sleep and appetite, lack of motivation, restlessness or agitation, fatigue or lack of 
energy, and thoughts of death or suicide (American Psychiatric Association, 1994a).  However, 
depression in teens can also manifest in atypical ways including unexplained aches and pains, 
extreme sensitivity to criticism, problems at school, reckless behavior or self-injury, or other 
unusual changes in behavior (National Institute of Mental Health; NIMH, 2008).  
Although it is normal for teenagers to experience emotional highs and lows (Offer, 1969), 
distinguishing between normal teenage mood swings and actual depression is critical for the 
welfare of the child and his/her family (Rutter et al, 1976).  Rates of depression in adolescents 
have been on the rise and are comparable to rates of adult depression.  This has been 
demonstrated by both national epidemiological surveys (i.e., The National Comorbidity Study 
[NCS], Kessler 2006) and in smaller community surveys of adolescents (e.g., Cohen et al., 
1993).  These disorders have a lifetime prevalence rate of 15 % to 20% during adolescence 
(Lewinsohn, Rhode, Klien, Seely, & Gotlieb, 2003), while current prevalence rates range from 
6% to 28.3 % (Kessler, 2002).  Other studies have shown that these rates are higher for Latino 
adolescents (Roberts, Roberts, & Chen, 1997).  A report from the Centers for Disease Control 
(CDC) identifies Hispanic students (34%) as being more likely than white or black students 
(28.8% and 26.5% respectively) to report symptoms of depression such as sadness and 




Prevalence rates rise dramatically in puberty, particularly for girls.  Lifetime prevalence 
for Major Depression in adolescent females is between 20.8% and 31.6 % (Kessler et al., 1993; 
Lewinsohn et al., 1993; Lewinshohn, Rhode & Seeley, 1998), and the prevalence of subclinical 
depression is as high as 59% (Roberts, Andrews, Lewinsohn & Hops, 1990).  These differences 
in gender may be attributed in part to differences in coping styles or due to hormonal changes 
that occur during puberty (Angold, Costello, Erkanli & Worthman, 1999). 
A study by Bennett, Ambrosini, Kudes, Metz, and Rabinovitz (2005) found differences in 
the symptom presentation of adolescent boys and girls.  A sample of 383 adolescents (218 girls 
and 165 boys) between the ages of 11.9 and 20.0 years, were assessed using the clinician 
administered Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-
SADS-PL; Kaufman, Birmaher, Brent, & Rao, 1997), the 21-item Beck Depression Inventory 
(BDI; Beck et al., 1961) and the Research Diagnostic Criteria (RDC; Spitzer et al., 1978).  
Results indicated that depressed adolescent girls tended to endorse more symptoms of self-
blame, self dissatisfaction, depressed mood, sleep problems and fatigue than depressed boys, on 
measures such as and the K-SADS and the BDI (Bennett et al., 2005).  Depressed boys on the 
other hand, were found to have higher levels of anhedonia, depressed morning mood, and 
morning fatigue, based on clinician ratings (Bennett et al., 2005). These results, with the benefit 
of a large sample size and the incorporation of clinician ratings, point to the emergence of 
potentially important differences that sex differences may play in the presentation of depression.  
 
Impairment and Comorbidity 
Depression in adolescence is associated with significant impairment (Puig-Antich et al., 




Rhode, Klein & Seeley, 1999).  Adolescents may suffer debilitating symptoms during their most 
productive years leading to academic, career, and family problems (Kessler, Avenevoli & 
Merikangas, 2001).  Even subclinical symptoms of depression are a substantial concern in youth, 
and are associated with a range of problems, including drug and alcohol use, academic failure, 
school dropout, and teen pregnancy (Gillham, Shatté, & Freres, 2000).  Moderate levels of 
depression can persist for years in some children (Twenge & Nolen-Hoeksema, 2002), and 
subthreshold levels of depressive symptoms are one of the most significant risk factors for the 
onset of later depressive disorders (Clarke et al., 1995; Pine, Cohen, Cohen, & Brook, 1999).  A 
recent study by Rhode, Beevers, Stice and O’Neil (2009) also found that adolescent girls with 
minor depression were approximately five times more likely to experience major depressive 
disorder (MDD) than adolescents without minor depression. 
In terms of education and occupational functioning, several key symptoms of depression, 
such as impaired ability to concentrate, loss of interest, poor initiative, psychomotor retardation, 
low self-esteem, sense of worthlessness as well as social withdrawal may significantly disturb 
cognitive performance and diminish initiative in learning (Beck, 1967; Hammen, 1998; 
Kirkcaldy & Siefen, 1998; Kovacs & Goldston, 1991).  Self-reported symptoms of depression 
are associated with impaired academic performance (Reinherz et al., 1991), and dissatisfaction 
with grades has in turn been predictive of subsequent major depressive disorder (Lewinsohn et 
al., 1994).  It is likely that cognitive functioning becomes impaired as the depressed adolescent 
concentrates on depressive thoughts and interpretations instead of the actual tasks, and/or 
because depression directly blocks cognitive resources (Hartlage, Alloy, Vázquez, & Dykman, 
1993).  In addition, failures and negative feedback received from parents, teachers or peers may 




Birmaher et al., 1996; Kendall & Lochman, 1994) or strengthen depressive thought(s) promoting 
learned helplessness, passivity, and avoidance (Seligman,1975).  
Evidence from community studies of children and adolescents show that depression is 
associated with a significantly high risk of anxiety disorders (Kovacs et al., 1989; Alessi et al, 
1987; Bernstein & Garfinkle, 1986) conduct disorders (Alessi & Robbins, 1984; Marriage et al. 
1986; Kovacs et al., 1986) eating disorders (Swift et al., 1986) and substance use disorders (e.g., 
Lewinsohn et al., 1993; Simonoff et al., 1997).  
The most severe consequence of depression in adolescents is suicide.  Major depressive 
disorder is identified as the leading cause of suicidal behavior and suicide in youth (Kann, 
Kinchen, Williams, Ross, Lowry, Grunbaum, et al., 2000; Brent, 2001). According to the World 
Health Organization (WHO, 2002), adolescent suicide accounts for at least 100,000 annual 
deaths worldwide.  Suicide ranked as the third leading cause of death among 10- to 14- year-old 
and 15- to-19- year-old age groups in the United States in 2000, with more than 2000 youth 
dying by suicide per year (Anderson, 2002).  Depression in youth continues to increase risk 
attempts (lethal and non-lethal) into adulthood (Weissman et al., 1999) which is indicative of the 
robust and pertinent relationship between depression in youth and suicide.  
 
Access to Mental Health Services 
Despite the large numbers of teenagers that struggle with clinical depression, adolescents 
are a largely underserved population that continues to be under-identified and/or under-referred.    
Studies show that less than 50% of adolescents and young adults aged 15 to 24 years use mental 
health services, and more disturbingly that 50% of depressed adolescents are not diagnosed prior 




many adolescents who meet criteria for a depressive disorder do not receive an adequate course 
of treatment (e.g., Lewinsohn & Clarke, 1999).   
 
Treatment 
Depression in adolescence is most commonly treated with medication or psychotherapy 
(Birmaher, Ryan, Williamson, Brent, Kaufman, 1996).  With regards to medications, selective 
serotonin reuptake inhibitors (SSRIs) such as fluoxetine, citalopram and sertraline are 
recommended for the treatment of depression, with fluoxetine having the strongest evidence in 
efficacy trials (Emslie et al., 1997; Emslie, et al., 2002).  The US Food and Drug Administration 
(FDA) approve the use of fluoxetine and more recently, escitalopram for treating depression in 
youth.  In terms of psychotherapy, cognitive behavioral therapy (CBT) is considered an 
established treatment for depression, supported by substantial evidence in both efficacy and 
effectiveness trials (Weersing & Brent, 2006; David-Fedron & Kaslow, 2008).  Although CBT 
has enough support to be considered as a monotherapy, recent studies have underscored the 
value of combination treatment which includes CBT and medication.  Results from the 
Treatment for Adolescents with Depression Study (TADS) indicated that after 12 weeks of acute 
treatment, the CBT plus medication group had the highest response rate followed by medication 
alone.  Similarly, the Treatment of Resistant Depression in Adolescents (TORDIA) study found 
that adolescents who received combined CBT and a change in medications were more likely to 
show an adequate clinical response as compared to adolescents who received a change in 
medication alone. 
Despite potential positive outcomes, there are certain barriers to receiving treatment. 




being labeled with a diagnosis of mental illness.  Parental perceptions of a child's mental health 
service needs may also be associated with receiving professional help (Wu et al., 1999) and 
psychiatric issues in children and adolescents may often be minimized or incorrectly identified 
(Clauss-Ehlers & Weist, 2002).  
It is for some of these reasons that offering services in a familiar setting such as schools 
may make treatment more acceptable (Catron & Weiss, 1994; Weist, 1999) since children may 
already receive school-based services for non-mental health concerns.  Schools have been 
designated as a key setting by the Surgeon General and present a crucial avenue for identifying 
and addressing mental health needs in youth (U.S. Department of Health and Human Services, 
1999) and making appropriate referrals for treatment when required.  Treatments and services 
delivered in schools or other community settings may be crucial for the well-being of adolescents 
and other school-aged children (Hoagwood, Burns, Kiser, Ringeisen, & Schoenwald, 2001; 
Hoagwood & Olin, 2002; Weisz & Jensen, 2001).  
 
Interpersonal Psychotherapy for Adolescents (IPT-A) 
In 2004, Mufson, Dorta, Moreau, and Weissman formulated Interpersonal Psychotherapy 
for Adolescents (IPT-A) based on Interpersonal Psychotherapy for adults (IPT; Weissman, 
Markowitz & Klerman, 2001).  Since its formulation, IPT-A has proven to be an efficacious 
treatment modality for adolescent depression (Mufson, Weissman, Moreau & Garfinkle, 1999 
Mufson et al., 2004; Rosello & Bernal, 1999).  IPT-A was adapted by Young and Mufson in 
2003 into Interpersonal Psychotherapy-Adolescent Skills Training (IPT-AST). IPT-AST is an 
adaptation of the group IPT-A manual (Mufson, Gallagher, Dorta & Young, 2004).  It is a group 




efficacy when compared to School Counseling (SC) in adolescents ages 11 to 16 years in school 
based clinics in New York City (Young, Mufson & Davies, 2006). 
Prevention programs fall into three categories on the basis of the populations to whom the 
interventions are directed, according to an Institute of Medicine Report (Mrazek & Haggerty, 
1994).  Universal preventive interventions are administered to all members of a particular 
population.  Selective prevention programs are provided to a subsample whose risk is deemed to 
be above average.  Indicated preventive interventions are given to individuals who manifest 
subclinical signs or symptoms of a given disorder.  
This study builds upon an indicated preventive study, based upon a randomized clinical 
trial conducted by Young, Mufson, and Gallop (2010) which tested the efficacy of IPT-AST and 
school counseling (SC) in adolescents, ages 12 -16 years, with elevated symptoms of depression. 
Results from the original study indicated that there was a significant difference in depressive 
symptoms and functioning between adolescents in the AST condition and those that received 
school counseling (SC), maintained at post-intervention and six-month follow-up.  
The aim of this study is to reanalyze the data from the IPT-AST study to evaluate 
differential patterns of symptom improvement within the treatment condition.  The results of this 
study will explore the process of change when adolescents with subthreshold depression are 
treated with IPT-AST treatments.  In order to do this, changes in mood/motivation and physical 
symptoms of participants who received preventive IPT-AST treatment will be traced across the 







Research suggests that early intervention for depression in adolescents can improve long-
term outcomes (Duffy, 2000).  Treatment choices for adolescent depression usually center on 
medications alone or in conjunction with psychotherapy.  Medications, specifically selective 
serotonin reuptake inhibitors (SSRI’s) have been shown to be efficacious in treating adolescent 
depression (Emslie et al., 2002; Emslie et al., 1997; Keller et al., 2001; Wagner et al., 2003). 
In terms of psychosocial treatments, both cognitive behavioral therapy (CBT) and Interpersonal 
Psychotherapy for Adolescents (IPT-A) have shown to be efficacious in the treatment of 
adolescent depression (Clarke et al., 1999; Lewinsohn, Clarke, Hops & Andrews, 1990; Mufson, 
Weissman, Moreau and Garfinkle (1999); Rosello & Bernal (1999).  Group therapy is also 
believed to be an effective treatment for adolescents with depression (IPT-AG; Mufson, 
Gallagher, Dorta & Young, 2004).  Because IPT-A is cost-effective and feasible, it can be 
delivered in a variety of settings including school, community and primary care clinics (Mufson, 
Dorta, Wickramaratne, et al., 2004). 
s 
Interpersonal Psychotherapy (IPT) 
IPT is an evidence-based treatment for the prevention and treatment of depression in both 
adults and adolescents.  It is a time-limited therapy based on the idea that depression can be 
treated by focusing on the patient’s depressive symptomatology within a current interpersonal 
context regardless of the etiology of the disorder (Weissman, Markowitz, & Klerman, 2000).  Its 
theoretical roots can be found in the interpersonal schools of thought and in the work of Adolf 




patterns of interpersonal interactions (Sullivan, 1953).  IPT focuses on the relationship between 
the depressive episode and current interpersonal stressors, encouraging individuals to find links 
between depressive symptoms and their social environment, and helps them make changes in 
their social and emotional interactions (Weissman, Markowitz, & Klerman, 2000).  A key step in 
using IPT involves identifying a primary interpersonal problem area.  The four main 
interpersonal areas are grief, interpersonal disputes, role transitions, and interpersonal deficits. 
Over the course of 16 sessions, the therapist and the patient work on one or two problem areas as 
part of the treatment.  In recent years, IPT has garnered strong empirical support for its 
effectiveness in the treatment of adult depression (de Mello, de Jesus, Bacaltchuk, Verdeli, & 
Neugebauer, 2005; O’Hara, Stuart, Gorman, & Wenzel, 2000; Talbot et al., 2005; Weissman, 
2007; Weissman, Klerman, Prusoff, Sholomskas, & Padian, 1981). 
 
Interpersonal Psychotherapy for Depressed Adolescents (IPT-A) 
 Interpersonal psychotherapy for adolescents (IPT-A) is an adaptation of IPT developed 
by Moreau, Mufson, Weissman, & Klerman, (1991).  It is considered to be a good match for 
depressed adolescents due to its brief duration, as well as focus on the present.  IPT-A also 
addresses interpersonal relationships and conflicts that adolescents are likely to be concerned 
about, and that are important to them.  We know from research that affect regulation deficits in 
children and adolescents are associated with higher levels of depression (Garber et al, 1995) and 
improvement in communication skills may have a protective effect against the development of 
depression (Carbonell et al, 1998).   IPT-A addresses several issues important to the 
developmental context of adolescents, such as major life choices in education, work, 




the art of negotiation.  The psychoeducation component of IPT-A which aims at building 
competencies and skills in the adolescent, addresses some of these issues. Finally, IPT-A is a 
treatment approach that can be easily disseminated to a variety of settings as it is manualized and 
brief.  Treatment typically lasts 12 weeks in duration, focuses on one particular interpersonal 
problem area, recommends parental involvement and plays a liaison role between schools and 
families (Moreau, Mufson, Weissman, & Klerman, 1991).  These aspects are particularly 
appealing to adolescents who may be reluctant to seek or stay in treatment. 
 The delivery of IPT-A is very similar to that of IPT, however there are some key 
differences between the two.  Modifications have been made to the IPT-A format to include an 
evaluation of drug abuse and suicidal behavior during the initial sessions.  Additionally, parents 
can play an important role in the treatment, and receive psychoeducation about depression, along 
with the adolescent.  Issues regarding termination are continually addressed during therapy to 
remind the adolescent of the time-limited nature of the treatment.  Skills gained during the 
treatment are frequently reviewed and the importance of an external support system for the 
adolescent is stressed.  Lastly, adolescents are reminded of the early signs and symptoms of 
depression so that they may recognize them and learn how to cope or seek help (Moreau et al., 
1991). 
 
Efficacy and Effectiveness of IPT-A 
IPT-A has been demonstrated to be an effective treatment modality for adolescent 
depression.  One of the first efficacy studies on IPT-A (Mufson, Weissman, Moreau & Garfinkle, 
1999) was a randomized clinical trial with 48 clinic-referred adolescents (ages 12-18 years) 




monitoring (CM; n = 24) with  therapist for twelve weeks.  Eligibility criteria for the study 
included meeting DSM-III-R criteria for a current depressive disorder and having a score of 15 
or higher on the HRSD (Hamilton, 1969).  Participants were administered an assessment battery 
bi-weekly by a blind independent evaluator to monitor their progress through the course of the 
study.  No significant differences were reported between the two groups at baseline in terms of 
either demographic or outcome measures.  Rates of recovery were defined as a score of less than 
or equal to six on the HRSD, and less than or equal to a score of nine on the Beck Depression 
Inventory (BDI).  The authors found that 75% of IPT-A patients met recovery criteria on the 
HRSD as compared to 46% of the control patients, a result that was significant at p= .04 level.  
Limitations of the study included using a small sample size (n = 24) comprised of predominantly 
Hispanic females.  Hence, this study was not representative of the general population, and given 
the stringent inclusion and exclusion criteria (as with all efficacy trials), the results may not be 
generalizable.  There was also a large drop-out rate in the clinical monitoring group which may 
have skewed the results obtained by the authors. 
In examining whether research therapy can be extended to the community setting, an 
effectiveness trial was conducted which compared IPT-A with treatment as usual (TAU) in 
school based mental health clinics in New York City (Mufson, Dorta, Wickamaratne, Olfson, & 
Weissman, 2004).  This 16-week randomized clinical trial included 63 adolescents aged 12 to 18 
years (mean age of 15) who were referred for mental health intake visits and met DSM-IV 
criteria for major depressive disorder, dysthymia, depressive disorder not otherwise specified, or 
adjustment disorder with depressed mood.   Participants were randomized to 12 sessions of either 
the IPT-A (n = 34) condition or the TAU condition (n = 29), which was defined as psychological 




adolescents who received IPT-A had significantly greater decreases in depressive symptoms on a 
clinician report measure (HRSD) and a self-report measure (BDI).  The IPT-A group also had 
greater overall functioning and social functioning at week 12 compared to the TAU group.  The 
study also used a predominantly Hispanic female sample which renders the results limited in 
generalizability. 
Rosello and Bernal (1999) also examined the effectiveness of IPT-A, comparing it to 
Cognitive Behavioral Therapy (CBT) and a wait-list control group (WC).  Their sample 
contained 71 adolescents ranging in age between 13 and 17 years of age who were randomly 
assigned to one of the three conditions (IPT-A, CBT or WC), where subjects received 12 weekly 
sessions conducted over 12 weeks.  The researchers found that both IPT-A and CBT treatment 
conditions were more effective than the control condition in reducing the depressive symptoms 
reported by adolescents.  IPT-A was found to be more effective in increasing self-esteem and 
social adaptability when compared to CBT, and participants in the IPT-A group benefited in their 
self-concept and social adaptation significantly more than participants in the wait-list control 
condition.  
The impact of comorbid anxiety on the effectiveness of IPT-A on depressed adolescents 
in the Mufson, Dorta, Wickamaratne, Olfson, and Weissman (2004) sample, was examined by 
Young, Mufson and Davies in 2006.  In this study, adolescents with and without probable 
comorbid anxiety disorders were compared on depression and overall functioning.  The authors 
found that comorbid anxiety was often indicative of a more severe depression, as indicated by 
higher depression scores at baseline.  Results indicated that regardless of the treatment group, 
depressed adolescents with comorbid anxiety had higher depression scores at the end of the study 




depression of adolescents with comorbid anxiety, however the results were nonsignificant (p 
=.07) indicating that IPT-A shows some promise as an effective treatment for this hard- to- treat 
combination of anxiety and depression. 
 
Group Adaptation (IPT-AG) 
IPT-A has been adapted to a group setting (IPT-AG) as group therapy is also believed to 
be an effective treatment for adolescents with depression (Mufson, Gallagher, Dorta, & Young, 
2004).  Working in a group format is advantageous because it enables members to perceive 
others who may be struggling like themselves and allow them to provide support for each other. 
It helps generate alternative solutions to conflicts and helps the individual learn more effective 
social skills by raising awareness of the needs and feelings of others (Corey, 1981 as cited in 
Mufson, Gallagher, Dorta, & Young, 2004).  Adolescents may find it particularly helpful to have 
others validate their feelings and experiences and receive advice from peers on what to do or 
how to handle a situation.  Additionally, IPT-AG is cost-effective (requires less staff for the 
treatment of more patients) and feasible in settings including school, community, and primary 
care clinics (Mufson, Dorta, Wickramaratne, et al., 2004). 
IPT-Adolescent Skills Training (IPT-AST; Young & Mufson 2003), based on IPT-A is 
also a group intervention that includes psychoeducation and interpersonal skill-building.  The 
treatment involves two individual pre-group sessions and eight weekly 90-minute group 
meetings.  Similar to traditional IPT, IPT-AST follows three stages (initial, middle, and 
termination).  It uses the interpersonal inventory to identify interpersonal problems that might be 
contributing to or exacerbated by their depressive symptoms, teaches interpersonal problem-




signs of depression.  IPT-AST differs from traditional IPT-A in that it does not focus on one 
particular interpersonal problem area for each adolescent to work on.  Rather, IPT-AST focuses 
on psychoeducation and general skill-building that can be applied to different relationships 
within the framework of 3 interpersonal problem areas: interpersonal role disputes, role 
transitions, and interpersonal deficits.   
The psychoeducation component focuses on defining prevention, identifying feelings, 
educating members about the symptoms of depression, and discussing the relationship between 
feelings and interpersonal interactions.  The interpersonal skill-building component comprises 
the teaching of communication and interpersonal strategies through games, role-plays, 
communication analysis, and didactics and later applying these skills to different people in their 
lives. 
A randomized trial by Young, Mufson, and Davies (2006) compared IPT-AST to school 
counseling (SC) as provided by school guidance counselors and social workers.  In their 
indicated prevention study, 41 adolescents, ranging between 11 to 16 years in age, with 
subthreshold levels of depression were assigned to the two conditions (IPT-AST, n = 27; SC, n = 
14) and compared on depressive symptoms, overall functioning and depression diagnoses post 
intervention and at follow-up.  Participants in the IPT-AST condition received two individual 
sessions and eight weekly group sessions.  Participants in the SC group were seen individually at 
a frequency determined by the student and the counselor.  
Results indicated that IPT-AST proved to be very successful in treating adolescents with 
subthreshold depressive symptoms.  Although children in both groups showed improvement in 
depression scores, adolescents in the IPT-AST group reported significantly fewer symptoms at 




1977) as compared to the SC group, which continued until the three-month and six-month 
follow-up.  The effect sizes for the main outcomes were large at post- intervention (ES = 1.52), 
at three-month follow-up (ES = 1.10) and at six-month follow-up (ES = 1.09).  Similar results 
were found for overall functioning as measured by the Children's Global Assessment Scale 
(CGAS; Schaffer, Gould, Brasic, et al. 1983). There was a significant difference between the two 
groups on the CGAS at post-treatment (ES = -.96), at three-month follow-up (ES = -.82) and at 
six-month follow-up (ES = -1.21; Young et al., 2006).  
A later study compared the efficacy of IPT-AST to a cognitive-behavioral program (CB) for 
preventing depressive symptoms in adolescents (Horowitz, Garber, Ciesla, Young & Mufson, 
2007).  The study also included a no-intervention control group. Three hundred and eighty 
participants were randomly assigned to one of the three conditions: cognitive-behavioral 
program (CB; n = 112), interpersonal psychotherapy–adolescent skills training (IPT–AST; n = 
99), or the assessment-only control condition (n = 169).  Both intervention programs involved 
eight 90-min sessions delivered once a week during students' regular wellness class period.  The 
authors found a significant but small short-term effect for both CB (d = 0.37) and IPT–AST (d = 
0.26) compared with controls for the entire sample at post-intervention.  However, the two active 
intervention conditions were not found to be significantly different from each other at post-
intervention or at follow-up (Horowitz, Garber, Ciesla, Young & Mufson, 2007). 
The relationship between psychological symptoms and physical symptoms in depression 
has not been adequately understood.  Although somatic symptoms such as sleep disturbances, 
and appetite/weight change accompany most types of depression (Nelson & Charney, 1981), few 
investigators have attempted to assess differences in the alleviation of physical and mood 




samples (Simons, Garfield & Murphy, 1983; Rush, Kovacs, Beck, Weissenburger & Hollon, 
1981; DiMascio, Weissman, Prusoff, & Neu, 1979).  
Despite IPT-A and its adaptations having demonstrated efficacy and effectiveness in 
randomized controlled trials in clinical settings (Mufson et al., 1999) and in school based clinics 
(Mufson et al., 2004; Rosello & Bernal, 1999; Young, Mufson, & Davies, 2006), the literature 
review presented above demonstrates that the nature and evolution of symptom change in IPT- A 
or its adaptations are virtually unknown, making it clear that further, more targeted analyses of 
change are necessary.  The current study was conceptualized to answer some of these questions 
and designed to analyze the timing and pattern of changes in mood symptoms in relation to the 
physical symptoms reported by patients with depression during preventive treatment with IPT-
AST. 
Review of Symptomatic Improvement Patterns in Psychotherapy and Pharmacotherapy through 
Clinical Trials 
 In a seminal paper titled “Modulation of Cortical-Limbic Pathways in Major Depression; 
treatment specific effects of Cognitive Behavior Therapy”, Goldapple et al., (2004) looked at 
changes in regional glucose metabolism measured with post-hoc positron emission tomography 
(PET) to contrast neural mechanisms associated with cognitive behavioral therapy (CBT) with 
those of a previous study of paroxetine treatment. The authors posited that disparate treatments 
have different primary targets of action—cortical “top-down” mechanism affiliated with 
response to CBT vs. subcortical “bottom-up” mechanisms associated with response to anti-
depressant pharmacotherapy.  The paper suggested that the time course of symptom changes 




views of self and mood precede changes in vegetative and motivational symptoms, and that this 
timeline is not typically seen in patients treated with medications. 
  Results of the Goldapple (2004) study indicated that regional changes following 
successful treatment with CBT and paroxetine treatment, involve cortical sites similar (and in 
some cases identical) to those seen with paroxetine and other medications, but as hypothesized, 
the changes were in the opposite direction.  Frontal and parietal decreases and hippocampal 
increases were seen with CBT response, whereas the reverse pattern was seen with paroxetine 
treatment. Hence, these results provide evidence that CBT and paroxetine have treatment specific 
change patterns and that each treatment targets different primary sites with CBT showing a 
cortical “top-down” target of mechanism and paroxetine treatment showing a subcortical 
“bottom-up” mechanism. 
The literature on the process of change during treatment for depression using 
psychotherapy is fairly limited.  Although research has focused on the comparison of treatments 
and attempted to gain an understanding of which patients may benefit from a given treatment and 
measured improvement over time, it has seldom qualified improvement by comparing specific 
symptoms or closely monitoring symptom change as it occurs during treatment.  This analysis of 
literature will include symptom pattern trends identified by cognitive behavioral therapy (CBT), 
interpersonal therapy (IPT) and psychopharmacotherapy using amytryptiline (a tricyclic 
medication) and fluoxetine (a selective serotonin reuptake inhibitor; SSRI). 
  
Trials with Cognitive Behavioral Therapy 
There is a growing body of evidence pertaining to adult symptom improvement specific 




changes using CBT than with any other form of therapy.  One of the earliest studies to look at 
mechanisms of change in therapy was by Zeiss, Lewinsohn, and Munoz in 1979.  Although the 
researchers were not interested in sequential improvement of symptoms, they examined the 
degree to which three treatment modalities (interpersonal modality, cognitive modality, and 
pleasant events schedule modality) would have specific effects on the behaviors directly 
addressed in the therapy modality (i.e assertiveness, social interaction, mood-related pleasant 
activities, irrational beliefs, and cognitions).  They defined interpersonal behavior modality as 
including three aspects of interpersonal behavior: assertion, interpersonal style of expressive 
behavior, and social activity.  The pleasant events schedule modality was designed to increase 
patients' frequency of pleasant activities by monitoring their enjoyment of potentially pleasant 
activities.  The cognitive treatment module included teaching participants about positive and 
negative thoughts, teaching strategies such as thought-stopping, increasing positive self-talking 
and disrupting irrational beliefs. 
 Sixty-six depressed participants were first screened using the Minnesota Multiphasic 
Personality Inventory Scale (MMPI; Grinker, Miller, Sabshin, Nunn, & Nunnally, 1961), and 
then classified as depressed and non-depressed based on the MMPI Depression Scale (MMPI D). 
Forty-four participants completed treatment and follow-up assessments.  In each treatment 
modality, half the participants received immediate treatment and the other half received delayed 
treatment.  Each of these treatments had been previously included in studies and had 
demonstrated improvement in depression levels (Graf, 1977; Lewinsohn, 1975; Youngren & 
Lewinsohn,1978; Libet, Lewinsohn & Javorek, 1973, & Beck, 1972).  Assessments included the 
Interpersonal Events Schedule (IES; Youngren, Lewinsohn & Zeiss, 1975), the Pleasant Events 




Munoz, 1977), the Personal Belief Inventory (PBI, Hartman, 1968; Munoz, 1977), the Subjective 
Probability Questionnaire (SBQ; Munoz, 1977), the MMPI D scale, as well as observer ratings 
of social and cognitive skills and peer ratings of social and cognitive skills based on group 
interactions.  
The researchers found that while all three treatments led to improvement, no treatment 
modality had a specific impact on the variables most relevant to its treatment format.  In fact, all 
patients improved on interpersonal, cognitive and daily functioning variables.  It is possible that 
non-significant findings were the result of the fact that all three treatments contained components 
of CBT (i.e cognition, behavior activation, assertiveness training), which may have reduced 
differences between conditions.  Also, not all of the assessments used in the study were 
standardized and were possibly not sensitive to differences that existed between the groups. 
Lastly, it is likely that since the same therapists carried patients in each treatment modality, there 
may have been contamination of treatments leading to non-specific findings.  
 A later study by Rush, Beck, Kovacs, Weissenburger and Hollon (1981) compared 
symptom improvement among depressed adults treated with either cognitive therapy or 
imipramine to evaluate whether there were any differences in how the two treatments affected 
measures of hopelessness and self-concept in depression.  Their randomized controlled trial 
included 35 depressed outpatient subjects who were assessed on the BDI (Beck et al., 1961) and 
the HRSD (Hamilton, 1969). Subjects with a score of 20 or higher on the BDI and 14 or higher 
on the HRSD (Hamilton, 1969) were accepted to participate.  Participants were randomly 
assigned to 11 weeks of treatment with either cognitive therapy (n = 18) or imipramine 
hydrochloride (n = 17).  The imipramine group received weekly 15-20 minute supportive 




BDI, the Hopelessness Scale (Heimberg, 1961), and the Miskimins Self-Goal-Other II (a 
measure of self-concept), where items were combined to specifically evaluate social and 
emotional aspects.  As a basis for analysis, treatment was grouped into two periods: weeks 1-5 
(early), and weeks 6-10 (late).  Two analyses of covariance were conducted. The first analysis of 
covariance was conducted to assess changes in pre-treatment hopelessness between treatment 
groups and a second analysis of covariance was conducted to assess changes in hopelessness 
with each treatment condition during the first weeks of therapy.  
The authors found that cognitive therapy exceeded imipramine in its impact on both 
hopelessness and general aspects of self-concept, and that cognitive therapy was especially more 
effective in reducing hopelessness within the first five weeks of treatment.  However, similar 
results were not found for the self-concept measure and this was explained by conferring that 
hopelessness was positively correlated with overall depressive symptomatology whereas self-
concept was not, leading to a difference in findings.  One of the major drawbacks of the study 
was that it did not include a control group or another therapy group, which would have provided 
more information as to whether the effects obtained were specific to cognitive therapy.  However 
these findings underscore the clinical implications related to the difference in effects of the two 
treatments.  Since hopelessness has been implicated in suicidal intent and attempts, and cognitive 
therapy produces a greater reduction in hopelessness, it is possible that it may have similar 
effects on symptoms of suicidality. 
  In a follow-up paper based on the same study, Rush, Kovacs, Beck, Weissenburger and 
Hollon (1981) addressed whether there were different patterns of symptom change associated 
with the two treatment modalities for depression that they investigated earlier (Rush et al., 1981). 




the self, hopelessness, mood, motivation and vegetative symptoms during the first four weeks of 
treatment (weeks 1-2, 2-3 and 3-4) for 35 depressed subjects, for each treatment condition.  
These time periods were selected since the fastest reduction in symptoms had occurred between 
weeks 1-4 in both treatment groups.  Their findings suggested that for the cognitive therapy 
group, improvements in hopelessness, views of the self and mood generally preceded changes in 
vegetative and motivation symptoms.  Further, although the researchers hypothesized that 
vegetative symptoms would improve with medications; no consistent patterns of symptom 
change were reported.  This finding was explained as a variation in response to pharmacotherapy 
between subjects and the possibility that the week-long interval was too long to detect any 
significant changes, since drugs were taken on a daily basis.  Their recommendations included 
obtaining measures of different symptoms (e.g. cognitive, vegetative, mood) more frequently 
during treatment in order to help understand the mechanisms of change.  
Continuing this line of research, Simons, Garfield and Murphy (1983) analyzed the 
process of change for depressed patients treated with cognitive therapy as compared to those 
treated through psychopharmacology (nortrypline hydrochloride).  Although subjects in their 
study were randomly assigned to four treatment conditions-- cognitive therapy, medication, 
cognitive therapy and medication, cognitive therapy and placebo, their paper compared only the 
two main treatment groups: cognitive therapy alone and pharmacotherapy alone for 12 weeks. 
The study included 28 participants, 14 in each group who scored 20 or above on the BDI, and 14 
or above on the HRSD.  Outcome measures were categorized as mood measurements (the 
HRSD, BDI and the Visual Analog Scale (VAS) and cognitive measurements (the Automatic 
Thoughts Questionnaire (ATQ), Dysfunctional Attitudes Scale (DAS), and the irrational –




four time points which included pre-treatment, week 4, week 8, and termination. Results were 
analyzed using a repeated measures multivariate analysis of variance (MANCOVA) design to 
test for the differential effects of treatment.  Although it was expected that both groups would 
improve on measures of mood, the authors hypothesized that there would be specific differences 
between the groups on the cognitive measures, since cognitive therapy and pharmacotherapy are 
two different forms of treatment and would likely impact cognitive symptoms differentially. 
However, their results did not support this hypothesis and indicated that both treatments did 
equally well in alleviating mood and cognitive symptoms (i.e. improvement in both groups was 
found to be similar in time course and magnitude, and both groups were found to have identical 
improvement on cognitive measures).  The authors justified their findings by stating that 
cognitive change should be seen as part of improvement and not a cause of improvement and 
that it was perhaps reasonable to infer that symptoms mutually influence one another and that 
cognitive symptoms most directly affect mood symptoms and vice versa.  
The findings from the Simons, Garfield and Murphy (1983) study were surprising and 
have implications for considering the ways in which cognitive therapy impacts cognitions and 
mood and leads to improvement in symptoms.  However the study’s liberal use of self-report 
measures (BDI, DAS, VAS, and CRT) and lack of a control group may have impeded its ability 
to tap into differential changes in cognitive symptoms between the groups, leading to 
inconclusive results.  
 
Trials with Interpersonal Psychotherapy 
Research on trends in symptom improvement in IPT is a nascent field and although there 




trends in symptom reduction for children, and adolescents treated with IPT or its adaptations.  To 
the best of our knowledge, the temporal dynamics of remission of subthreshold symptoms of 
depression in adolescents has not been investigated yet.  Therefore, the importance of the current 
study lies in its ability to fill this gap in research while also maintaining relevance through the 
clinical implications it stands to provide.  Since research has demonstrated the similarities 
between adolescent and adult depressive symptoms (Ryan et al., 1987), we turn to the research 
on trends using IPT with adults as a starting point to the current study. 
Perhaps the only study to discuss differential symptom reduction using short-term IPT 
with adults was a randomized controlled trial by DiMascio, Weissman, Prusoff, and Neu (1979) 
which compared the effect of  tricyclic anti-depressant medication (amitriptyline hydrochloride) 
and IPT, conducted over 16 weeks, each alone and in combination, in acutely depressed patients. 
A nonscheduled treatment control group was also included in this study which allowed patients 
to receive periodic supportive psychotherapy on demand.  Eighty-one depressed outpatient adults 
were assessed using the Schedule for Affective Disorders and Schizophrenia (SADS; Endicott & 
Spitzer, 1978), the Research Diagnostic Criteria (RDC; Spitzer, Endicott & Robbins, 1975), the 
HRSD (Hamilton, 1969), with scores of seven or higher on the Raskin Three Area Depression 
Scale.  Participants were randomly assigned to one of four treatment groups: psychotherapy 
alone (n = 25), pharmacotherapy alone (n = 24), psychotherapy plus pharmacotherapy (n = 24) 
and nonscheduled treatment (n = 23).  Separate analyses were carried out at weeks 1, 4, 8, 12 and 
16 and the study was analyzed by a three-way analysis of covariance, using a fixed-model least 
square analysis.  The authors found that both amitryptyline and psychotherapy lead to overall 
symptom reduction and that the effects of both treatments in combination were additive (i.e. 




amitryptyline affecting vegetative symptoms such as sleep and appetite disturbance within the 
first week in the treatment and IPT affecting mood, suicidal ideation, work, and interests later at 
four to eight weeks compared to the control group). Interestingly, the effect of pharmacotherapy 
on mood and on interest occurred much later at 12 weeks.  Both individual treatments were 
found to be equally efficacious and better than the non-scheduled treatment.  These findings 
indicate that symptoms of mood and motivation (interest) may be more amenable to changes 
with IPT, with differences occurring as early as four weeks, whereas physical symptoms may be 
more amenable to medication treatment with improvements occurring within the first week.   It 
would be interesting to know whether IPT was found to impact vegetative symptoms in the 
group and if so, at what time period, as this data was not reported by the authors. 
In order to answer some of these questions, a pilot study  by Sinh, Chaudhury, Verdeli, 
Tang and Young (unpublished) explored patterns of improvement in a sample of adolescents 
with subclinical depression symptoms, treated with IPT-AST in three school-based clinics in 
New York City (Young, et al., 2006).  As reported previously, the original authors Young et al. 
(2006) had found IPT-AST to be effective in reducing the subthreshold depression symptoms of 
these adolescents compared to school counseling.   
Using the depression symptom checklist (a non-standardized clinical tool), patterns of 
improvement of mood/motivation and vegetative symptoms were followed from baseline to six 
(of the original eight) weeks of treatment.  The authors categorized three time points (weeks 1, 3, 
and 6), to classify subjects as “early responders” (those that showed a 50% reduction in 
symptoms by week 3), “late responders” (those who showed a 50% reduction in symptoms by 
week 6), and “non-responders” (those who did not show a 50 % reduction in symptoms by week 




improvements in vegetative symptoms.  Results of the study were in the intended direction, and 
indicated that symptoms of mood and motivation improved more rapidly than physical 
symptoms, however the difference in the rate of improvement between the two clusters (i.e., 
mood/motivation and vegetative) was found to be non significant. These results may be 
explained by the sample size (n = 27) of the study which did not allow for enough power to 
detect significant differences in improvement, even had they existed.  It is also likely the 
differences would have been more significant closer to the termination of treatment (i.e., at the 
end of eight weeks) hence the decision to include six weeks in the analysis may have decreased 
the likelihood of uncovering true differences in rate of symptom improvement.  
 
Trials with Psychopharmacotherapy 
Recognizing that physical symptom changes in depression are closely linked to changes 
in depressed mood, a study by Casper et al., (1994), analyzed sequential patterns of physical, 
mood and cognitive symptom changes in depressed patients who received antidepressant 
medication (amitriptylin or imipramine) over four weeks.  In order to assess behavioral change 
and outcome, the researchers used diagnostic instruments including the Schedule for Affective 
Disorder and Schizophrenia (SADS; Spitzer et al., 1978), the Hamilton Depression Scale 
(Hamilton, 1960), the Global Assessment Scale (GAS; Endicott et al., 1976), the SADS change 
form (SADS-C; Endicott & Spitzer, 1978), the Clinical Global Impression scale (CGI; Guy, 
1976), the Video Interview Behavior Evaluation Scale (VIBES; Katz & Itil, 1974), the Hopkins 
Symptom Checklist -90 (HSCL-90; Derogatis et al., 1974) and the nurse- rated Affective 
Disorder Rating Scale (ADRS; Murphy, Pickar, & Alterman, 1980).  The authors compared 




responders”, and 27 who were categorized as “poor responders”.  Patients in the good responder 
group were rated as markedly or completely improved after four weeks of drug treatment versus 
the poor responders; patients who were rated as having responded minimally to treatment (as 
measured by a score below 16 on the Hamilton Depression Scale and over 60 on the Global 
Assessment Scale).  Patients who had an intermediate treatment response were excluded from the 
analysis.  Comparing physical symptoms such as sleep impairment, loss of appetite, loss of 
sexual interest and diurnal mood changes to depressed mood, the authors hypothesized that both 
physical and mood symptoms would ameliorate around the same time in a related fashion. 
However results indicated that although changes in appetite, weight, libido and diurnal mood 
variation paralleled changes in depressed mood, sleep changes (and early alleviation of insomnia 
in particular) preceded the improvement in depressive feelings by the first week of drug 
treatment in good responders.  Although the authors did not specifically comment upon the time 
course of amelioration of mood symptoms, their results are partly consistent with Di Mascio et 
al’s (1979) study which also found that amytriptyline lead to reductions in sleep disturbances 
within the first week of treatment.  However, unlike the DiMascio et al (1979) study, this study 
found changes in mood and other vegetative symptoms to occur at approximately the same time. 
Limitations to the study include a lack of placebo control group which might have elucidated the 
specific effects of medication on the groups, as well as the order or time-line of symptom 
improvement that emerged. Further, although details were not reported in the paper, cognitive 
symptoms were not found to follow the time-line of mood and vegetative symptom 
improvement. 
An open label trial by Worthington, Fava, Davidson, Alpert, Nierenberg and Rosenbaum 




over eight weeks.  Their study included 62 depressed outpatients between the ages of 16-85 
years, diagnosed with major depressive disorder.  Participants were screened using the Structured 
Interview for DSM-III-R- Patient Edition (SCID; Spitzer et al. 1989) and had a score of greater 
or equal to 16 on the 17- item Hamilton Rating Scale for Depression (HAM-D-17; Hamilton, 
1960) at both screen and baseline visit.  Patients who showed “full response” following 
fluoxetine treatment were included in the study, where full response was defined as a HAM-D-
17 score of lesser than or equal to seven, for at least two consecutive weeks by the end of the 
eight weeks of treatment.  In order to monitor for changes in depressive symptoms, subjects were 
administered the 28-item version of the HAM-D (Fava et al., 1993) at screening, baseline, and 
every two weeks for eight weeks.  The study classified patterns of improvement as (a) early 
complete improvement (defined as greater than or equal to 75% improvement from baseline 
score occurring during the first four weeks of treatment and maintained until the end), (b) early 
partial improvement (defined as greater than or equal to 50% improvement from baseline score 
occurring during the first four weeks of treatment, and (c) late complete improvement (defined as 
greater than or equal to 75% improvement from baseline score occurring during the last four 
weeks of treatment).  Using chi-square method of analysis, the authors evaluated overall 
differences in patterns of improvement and found that suicidal ideation, excessive guilt, and lack 
of appetite improved significantly earlier during treatment in comparison to depressed mood. 
Depressed mood, reduced interest and hypersomnia tended to improve during the last four weeks 
of treatment in about half of the responders.  Drawbacks to the study include that as an open-
label trial, some responses may have been due to non-specific, placebo-like effects. Also, ratings 
of depression were completed by physicians not blind to the study; hence investigator bias is a 




have helped clarify trends of symptomatic improvement.  And lastly, as with any medication 
trial, certain fluoxetine induced side effects may have confounded the assessment of 
symptomatic improvement. 
Literature Review Conclusions 
In light of some of the findings discussed above on the process of change involved in 
CBT treatment, it seems that improvement in hopelessness and views of self and mood generally 
change before vegetative and motivation symptoms (Goldapple, Segal, Garson, Lau, Bieling, 
Kennedy & Mayberg, 2004).  With one exception (Simon, Garfield & Murphy, 1983), a similar 
time line was not seen in patients treated with pharmacotherapy.  The TADS and TORDIA trials 
which included medication and psychotherapy using CBT for the treatment for adolescent 
depression highlight the value of combined medication and psychotherapy.  
Although there is some preliminary information with regard to changes in symptoms with 
adults (DiMascio, Weissman, Prusoff, & Neu, 1979), the picture is still rather unclear for IPT 
and its adaptations.  With regard to IPT-A, it is not known specifically which symptoms would 
improve first or how soon they would improve for depressed adolescents.  Additionally, research 
has not consistently classified symptoms as one of mood, physical or cognitive, giving rise to 
ambiguity about whether a symptom may be included in one cluster or the other.  
This study therefore seeks to explore what trends might emerge, utilizing the group 
receiving IPT-AST in the indicated preventive intervention in Young, Mufson and Gallop’s 2010 
study.  The present analysis explores the patterns of symptom improvement among 
(predominantly Hispanic) participants in the IPT-AST condition, whose improvements in 





These divergent paths of recovery in this sample are important to evaluate for several 
reasons.  From a cultural perspective, even though Latinos/as are now the largest minority group 
in the United States, few treatment studies include participants of this ethnicity and others fail to 
analyze data based on minority group membership (Hall, 2001; Miranda et al., 2005).  The bias 
in psychological sciences to study white, middle class English-speaking individuals is well 
documented (Bernal & Scharron-del-Rio, 2001).  
IPT is considered a good candidate for cultural adaptation because of the strong body of 
evidence on its efficacy.  Further IPT has several elements that are consonant with Latino culture 
including: (1) focusing mainly on current interpersonal conflicts which are tied into Latino 
values (Bernal & Enchautegui, 1994) of familioso that is placing the interest of the family over 
the individual and personalismo that is preference for personal contact in social situations, (2) 
having a problem-solving approach (3) a didactic orientation and format that educates about 
symptoms and the process of therapy and (4) receiving active intervention from an “expert” 
(Rosello, Bernal & Rivera-Medina, 2008). 
From a theoretical standpoint, mechanisms of symptom improvement over the course of 
IPT are virtually unknown.  Depression as an illness includes symptoms which can be classified 
on the basis of mood (e.g. depressed mood--feeling sad or empty), somatic or neurovegetative 
symptoms (e.g. changes in appetite, weight, sleeping pattern, fatigue and psychomotor 
agitation/retardation), motivation (e.g. diminished interest or pleasure), and cognition (e.g. 
diminished ability to think or concentrate).  These factors jointly impact the ability of an 
individual to function and may in turn be differentially affected by the intensity of the illness. 
Some patients may experience more serious mood symptoms, whereas others may find that they 




Hence, the treatment that produces more rapid changes in a particular cluster of symptoms (i.e. 
appetite, weight loss, insomnia) may be an indication for patients who are impaired within that 
cluster.  
Third, as clarified by results discussed earlier, physical symptoms can abate as early as 
within the first week of treatment with psychotropic medication (Casper et al., 1994; DiMascio et 
al., 1979), whereas mood and motivation symptoms tend to improve later--by four weeks or so 
(DiMascio et al., 1979; Rush et al., 1981).  Given that the risk of completing a suicide is higher 
for patients who experience relief from physical symptoms but continue to experience sadness 
and hopelessness, there tends to be a time-lag in treatment which may inadvertently raise a 
suicidal patient’s risk of making or carrying out an attempt.  Mental health services are 
increasingly aiming to individualize treatments by matching patients to interventions based on 
their symptom profiles.  Hence, this study may add to the knowledge base on depression in teens 
and appropriate clinical interventions that can be made on the basis of presenting problems. 
Lastly, as stated earlier, research is lacking information about depression symptom 
improvement in adolescents and on subclinical depression.  Because subclinical depression 
constitutes as a major risk factor for the subsequent onset of depression (Clarke et al., 1995; 
Pine, Cohen, Cohen, & Brook, 1999),  and has been found to persist for years in some children 
(Twenge & Nolen-Hoeskema, 2002), this study has significant public health implications. 
Therefore there are both theoretical and clinical gains in conceptualizing and studying teens with 







Aims and Hypotheses 
The overall aim of this dissertation is to evaluate patterns of symptom improvement 
within the IPT-AST treatment condition of the original Young, Mufson & Gallop (2010) study. 
Specifically we wanted to explore whether there would be any differences in mood/motivation 
symptom improvement and vegetative symptom improvement for teens who received the IPT-
AST preventive treatment.  
Aim 
Measure differences in patterns of mood/motivation and vegetative symptoms in adolescents 
treated with IPT-AST. 
Hypothesis 1  
Improvements in mood/ motivation symptoms will precede improvements in vegetative 
symptoms as measured by the depression symptom checklist. 
Hypothesis 2 
Controlling for baseline levels of mood/motivation and vegetative symptoms, adolescents 
who show improvements in mood/motivation symptoms will also show improvements in 
vegetative symptoms. 
Exploratory Analysis 
The study also aimed to examine the effect of moderators as well as look more closely at 
the relationship between mood/motivation, vegetative and total depression symptoms at baseline 
and termination. 
Results from this dissertation analysis have the potential to provide practitioners as well 
as caregivers information regarding the process of symptom improvement in adolescents with 




awareness among the mental health community about the abatement of symptoms as they occur 
following response to IPT-AST. In terms of clinical treatment, it may provide a means of 
identifying teenagers who are most likely to experience benefit from this preventive treatment. 
Knowing about the pattern of improvement following treatment or being aware of a given 
presentation of symptoms in an adolescent would facilitate treatment individualization by 
informing clinicians regarding the factors that may increase risk, and the options and choices 
available to them, and what might work specifically for a person. For an adolescent presenting 
with, or responding to treatment with more mood/motivation symptoms and less vegetative 
symptoms may prompt a different referral than for an adolescent presenting with, or responding 
to treatment with more vegetative and less mood/motivation symptoms. Hence, the study will 
help to provide a more thorough understanding of the nature and the timing of response to IPT-










This study is a secondary analysis of an existing dataset from a randomized trial that 
evaluated the efficacy of an indicated prevention program for adolescent depression.  The 
description of the preventive intervention, the trial, and its termination and 6-month follow-up 
results were reported previously (Young, Mufson & Gallop, 2010) and will be briefly 
summarized here.  
 
Participants 
Participants in the original IPT-AST preventive study were chosen from three single-sex 
high schools (two girls’ schools and one boys’ school) in New York City. Eligible participants 
were male and female students, in the 9th and 10th grades who met the study criteria for 
subsyndromal depressive episode (defined as at least two subthreshold or threshold symptoms on 
the K-SADS-PL), who had CES-D scores between 16 and 39, who did not meet criteria for a 
current depressive episode and had a C-GAS score of 61 or higher.  Other exclusionary criteria 
included a current diagnosis of depression, dysthymia, bipolar disorder, psychosis, panic 
disorder, obsessive-compulsive disorder, post-traumatic stress disorder, oppositional defiant 
disorder, conduct disorder, or untreated attention deficit hyperactivity disorder.  Fifty-nine 
adolescents who met these criteria participated in the study; 36 in the IPT-AST group and 21 in 
the school counseling (SC) or treatment as usual group.  
The final sample for this study consisted of 32 participants who were originally selected 
from the 36 adolescents included in the IPT-AST condition in the Young, Mufson and Gallop 




be excluded from our analyses.  Participants were 18 girls and 14 boys ranging in age from 13 to 
17 years enrolled in the 9th and 10th grades.  Their average age was 14.53 (SD = .72) years and 
there were more females than males in the study (56.3 %).  In terms of ethnicity, 65.6 % of 
adolescents identified themselves as Hispanic.  In terms of race, 59.4 % of participants were 
White, and 40.6 % were African American.  Most adolescents (65.6 %) lived in a dual-parent 
household and 12.5 % reported a gross household income of $25,000 or less.   
 
Procedure 
In the original Young, Mufson & Gallop (2010) study, potential trial participants with 
elevated symptoms of depression were identified through a two-stage screening procedure.  The 
process of recruitment for the study began in November 2005 and ended in February 2007. See 
Appendix C on page 99 for study recruitment flow chart.  
Screening:  The first stage of screening took place in the form of a classroom-based 
screening.  A letter was sent out to the parents of students in the 9th and 10th grades with 
information regarding the study by school administrators.  Parents who did not want their child 
to participate in the study could send back a notice of refusal.  If a refusal letter was not received, 
another letter was sent, thus providing parents with two opportunities to refuse participation.  On 
the day of the screening, information was provided to adolescents regarding the study procedures 
and those who were willing to participate signed a screening assent form.  Eventually, three 
hundred forty-six (30.98%) parents and 125 (11.19%) adolescents refused participation in the 
study.  There were also four adolescents who were repeatedly absent, and were also not included.  
The second-stage of the screening consisted of having adolescents complete the CES-D 




Adolescents were considered eligible for the study if they had a CES-D score between 16 and 39; 
those with a score of 40 or higher were seen by the Principal Investigator (PI) to assess clinical 
severity and determine potential eligibility.   
The average CES-D score of the 642 adolescents was 15.23 (SD = 10.27) and the total 
number of adolescents that scored between 16 and 39 on the CES-D were 235.  Two adolescents 
scored 40 or above but were considered eligible to participate in the preventive study as they did 
not meet criteria for a depressive episode when assessed by the PI.  Families of adolescents that 
were found to be eligible were contacted by the research staff to describe the prevention project.   
Families that were interested in having their child participate came to the school to learn 
about the project and provided informed consent and assent to participate in an eligibility 
evaluation and the prevention program.  A third of the families (N = 79) agreed to participate in 
the project.  The two most common reasons identified for refusal to participate in the study were 
disinterest on the part of the adolescent (25.58%), parents (11.63%) or both (13.95%), and lack 
of perceived need (30.23%).  The adolescents who had consented to participate in the prevention 
component of the project were compared to those who had refused to participate on several key 
variables.  No significant differences were found in age (14.42 versus 14.34; t(235) = -0.86) or 
gender (56.96% female versus 62.03% female; χ2 = 0.45) between the two groups.  However, 
there was a significant difference on screening CES-D scores (26.37 versus 22.83; t(235) = -4.10, 
p < .01); adolescents who had agreed to participate had higher depression scores than those who 
had refused.  
Structured Clinical Interview and Assessments: The adolescents who consented to participate 
in the project completed the K-SADS-PL (Kaufman, Birmaher, Brent, & Rao, 1997) and the 




or threshold depression symptoms on the K-SADS-PL who did not meet criteria for a current 
depressive episode, were considered eligible.  A CGAS score of 61 or higher was also required 
for eligibility.  Adolescents with a current diagnosis of depression, dysthymia, bipolar disorder, 
psychosis, panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder, 
oppositional defiant disorder, conduct disorder, or untreated attention deficit hyperactivity 
disorder were excluded from the prevention study.  Four adolescents were excluded because they 
did not have enough depression symptoms; 10 because of a current depression diagnosis, suicidal 
ideation or self-harm behaviors; seven adolescents met criteria for one of the other exclusionary 
diagnoses.   
Assignment to groups: Using a table of random numbers, 57 adolescents were randomly 
assigned to either the IPT-AST or the School Counseling (SC) conditions.  The random number 
table was generated to ensure that approximately two-thirds of adolescents in each school would 
be randomized to the IPT-AST condition.  In this way, 36 adolescents were randomly assigned to 
the IPT-AST condition and 21 were randomly assigned to SC.   The two schools were also 
randomized to include parent participation in the IPT-AST condition in either the first or second 
year of the study.  The IPT-AST group without parental involvement (AST) comprised of 21 
adolescents and the IPT-AST group with parental involvement (ENH) comprised of 15 
adolescents.  The groups were combined due to improper randomization of subjects to groups in 
the original study.  The current study was unable to use the data of four participants as it was 












Assessment of depressive symptomatology 
 
 The current study used a single instrument-- The weekly depression symptom checklist, 
which subjects in the IPT-AST group completed prior to each group session.  Typically, an 
adolescent who attended all group sessions would have completed a total of eight weekly 
depression symptom checklists.  The weekly depression symptom checklist was used as a 
clinical tool in the original study and is not a standardized (i.e. reliable or valid) measure of 
depression/depression symptoms.  The checklist included questions which record changes in 
mood, physical, cognitive, and suicidal symptoms on a 3-point rating scale.  Responses were 
recorded as “Yes, Sometimes and No.”  
For the purposes of the present study, the checklist (see Appendix B, page 98) consisted 
of two distinct clusters—Mood /Motivational and Vegetative symptoms cluster. 
Mood/Motivational Symptom Cluster 
Questions in the mood/motivation cluster included items that assessed the affective 
experiences of adolescents in the last week.  They included question numbers 1, 2, 3, 4, 5 and 10 
from the depression symptom checklist, e.g. “Have you felt sad a lot?” “Have you felt hopeless 
that things may never get better?” “Have you gotten mad easily- sometimes over little things?” 
“Has it been difficult to have fun doing things you used to enjoy?” and “Have you felt guilty 
about things that may not be your fault?”  
Vegetative Symptom Cluster 
 The vegetative symptoms cluster assessed any physical symptoms experienced by 




checklist, e.g. “Have you had trouble falling asleep or staying asleep?” “Have you felt more or 




Adolescents in the IPT-AST condition had two pre-group individual sessions and eight 
weekly 90-minute group sessions.  All of the sessions took place in the schools.  The pre-group 
individual sessions occurred during students’ free periods or after school and the group sessions 
took place after school.   Four groups without parental involvement (AST) and three groups with 
parental involvement (ENH) were conducted over the course of two years.  The primary 
investigator of the original study co-led two of the groups.  The other group leaders were either 
masters or doctoral level psychologists or child psychiatrists who were trained and supervised by 
the primary investigator of the original study.  Each group contained four to six adolescents. 
Pre-Group meeting: During the pre-group meetings, an assessment of depressive symptoms 
was carried out by the leader who also provided a framework for the group and completed the 
interpersonal inventory with the adolescent in order to identify interpersonal goals to be 
addressed in the group.   
Group meeting: The group helped educate adolescents about the symptoms of depression, the 
link between feelings and interpersonal interactions and taught communication and interpersonal 
strategies that can be applied to improve relationships in their lives.  In the ENH groups which 
included parental involvement, parents participated in one of the two pre-group sessions with the 
adolescent.  Parents also participated in a mid-group parent-adolescent session to work on an 




progress or point out any additional work to be done.  If a parent was absent or unable to attend 
the session, the adolescent met alone with the group leader.  The other group (AST) did not 
receive any parental involvement, but was similar in all other respects to the parental 
involvement group. 
School Counseling   
Adolescents in the SC group were referred to the school counselor to be seen at a frequency 
determined by the adolescent and the counselor.  In the original study, SC was chosen as the 
comparison group because it approximates what normally occurs in the schools.   
SC sessions consisted of supportive individual counseling and were 30-45 minutes in 
duration.  Some topics discussed in these sessions included relationships with parents (35.14%) 
and academic issues (24.32%).  A variety of other topics (e.g., stress, peer relations, 
extracurricular activities) were also discussed.  One adolescent from the SC condition was 
hospitalized for several weeks due to depression during the follow-up period and subsequently 
withdrew from the study.  Five additional adolescents reported seeing the school counselor 
during the follow-up.   
The current study did not utilize the data of the SC group, as this group was not required 










This chapter focuses on the results of the analyses performed to address the research 
questions of this study.  In the first section, the operationalizations and statistical analysis 
strategy will be described. In the second section, descriptive statistics for the sample background 
characteristics are provided, along with reliability coefficients and descriptive statistics for the 
mood/motivation scores and the vegetative scores for each week of the study.  Then, each of the 
aims and hypotheses of this study are reviewed, and the results for each are presented.  The 
chapter ends with a summary of the key findings from this study.   
The review of the literature revealed a lack of consistency in terms of which symptoms 
were included to create particular clusters i.e mood/motivation, vegetative and cognitive clusters.  
Initially, the current investigation sought to focus on vegetative symptoms, cognitive symptoms 
and combined motivation and mood symptoms from the depression symptom checklist in our 
analysis.  However, the number of cognitive symptoms was too few in order for us to carry out 
any meaningful comparisons in differential improvement between the three clusters.  Thus, we 
decided to include five vegetative and six mood/motivation symptoms as part of our analyses.  
As mentioned earlier, responses on the checklist were recorded as “Yes, Sometimes and No.” 
During the data analysis, “sometimes’ and “yes” responses were scored as 1 and “No” was 
scored as 0. 
Since the two clusters (mood/motivation and vegetative) contained an unequal number of 
items (six for mood, and five for vegetative), we used standardized means in the analysis of most 




regression, early/late/no change classification and the ‘no improvement’ graphical analysis). 
Two-tailed tests and an alpha level of .05 were used for all inferential tests. 
 
Missing Data 
In order to account for missing data across the eight weeks of preventive treatment, the 
study employed three techniques. The first method consisted of averaging bi-weekly mean 
symptom scores leading to 4 time-points of assessment.  Time l indicates the average mean mood 
and vegetative scores at weeks 1 and 2, Time 2 indicates the averaged mean scores from weeks 3 
and 4, Time 3 includes averaged mean scores from weeks 5 and 6, and finally Time 4 indicates 
averaged mean scores from weeks 7 and 8.  For participants missing data at either week points 
(for example week 1), their Time 1 score consisted of the average of their mean week 2 scores.  
For those participants with both week 1 and week 2 scores available, their Time 1 score 
comprised of the average of their mean week 1 and week 2 scores.  Most of the analysis in this 
dissertation used “Time” data in order to arrive at the results. However the Poisson analysis 
employed weekly total scores (and not mean scores) as Poisson requires integer values. 
The second method used to work with the issue of missing data consisted of imputations, 
where scores from the last time point were carried forward. This method was used in the “no 
symptom improvement” analysis where subjects whose week 1 or week 8 scores were missing, 
were substituted by their week 2 or their week 7 scores. For participants missing any further data 
during the week time points, Maximum Likelihood Estimation was used to estimate the most 







In this section of the results, descriptive statistics for study variables including age, 
gender, race, and ethnicity are provided.  Table 1 contains descriptive statistics for these 
variables.  The majority of the participants (56.3%) were female, and most (65.6%) were 
Hispanic.  Racially, most of the participants (59.4%) stated that they were Caucasian.  Most of 
the participants (65.6%) lived in dual-parent households, and although most came from 
households (84.4%) which had a gross income greater than $25,000, the range of the income 






Demographic and Background Characteristics for Categorical Variables 
   
 Frequency Percentage 
   
   
Gender    
   
Female 18 56.3 
Male 14 43.8 
   
Ethnicity   
   
Hispanic 21 65.6 
Non- Hispanic 11 34.4 
   
Race   
   
White 19 59.4 
African American 13 40.6 
   
Parental Status   
   
Single-parent household 11 34.4 
Dual- parent household 21 65.6 
   
Annual household income   
   
Less than $25,000 4 12.5 
More than $25,000 27 84.4 
Missing 1 3.1 
   
   
 M SD 
   
   
Age 14.53 .72 
   






Table 2 shows descriptive statistics for the mood/ motivation scores and for the 
vegetative scores (computed as the mean item score at each time point for each scale).  Based on 
the values from this table, it can be seen that there was a tendency for mood/ motivation scores 
and vegetative scores to decrease over the eight weeks examined in this study.  
 
Table 2 
Descriptive Statistics for Composite Scores as a Function of Week 
       
 Mood/ Motivation Vegetative 
       
Week n M SD n M SD 
       
       
Week 1 23 .58 .38 23 .74 .51 
       
Week 2 24 .51 .33 24 .75 .56 
       
Week 3 24 .34 .30 24 .67 .53 
       
Week 4 21 .52 .38 21 .83 .51 
       
Week 5 22 .38 .33 22 .80 .57 
       
Week 6 27 .41 .45 27 .53 .48 
       
Week 7 21 .38 .37 21 .49 .49 
       
Week 8 28 .26 .33 28 .41 .42 
       
       
 
Table 3 shows reliability coefficients (Kuder-Richardson internal consistency reliability 
coefficients) for the composite mood/motivation scores and the vegetative scores for each week. 
In two cases (Week 2 mood/motivation scores and Week 5 mood/motivation scores), the 




3, and 4, and vegetative scores in Weeks 1, 4, 6, and 8), the reliability coefficients were between 
.60 and .70. In the remaining seven cases, the reliability coefficients were greater than .70.  
 
Table 3 
Kuder-Richardson Internal Consistency Reliability Coefficients 
   
 Scale 
   
Week Mood/Motivation 
 (6 items) 
Vegetative  
(5 items) 
   
   
Week 1 .62 (n = 23) .63 (n = 23) 
   
Week 2 .50 (n = 24) .76 (n = 24) 
   
Week 3 .60 (n = 24) .75 (n = 24) 
   
Week 4 .66 (n = 21) .62 (n = 21) 
   
Week 5 .56 (n = 22) .74 (n = 22) 
   
Week 6 .81 (n = 27) .63 (n = 27) 
   
Week 7 .72 (n = 21) .75 (n = 21) 
   
Week 8 .74 (n = 28) .61 (n = 28) 
   
   
 
Hypothesis 1 
The first aim of this study was to measure differences in patterns of mood/ motivation, 
and vegetative symptoms within the IPT-AST condition.  It was hypothesized that among 
adolescents treated with IPT-AST, improvements in mood/motivation will precede 
improvements in vegetative symptoms, as measured by the depression symptom checklist.  The 




The first method to examine the first aim of this study was to test whether there had been 
a specific significant decrease in mood/motivation and vegetative symptoms over the 8 weeks of 
preventive treatment. The results from the Young, Mufson & Gallop (2010) study had found 
significantly greater rates of change in depressive symptoms and overall functioning from 
baseline to post-intervention, however rate of change in terms of the two clusters had not been 
studied by the original authors and hence needed to be determined prior to analyzing the 
relationship between the two clusters.   
The Poisson regression was used to test for overall significance in improvement in the 
two clusters and used weekly data, comparing total symptom scores at Week 1, Week 4, and 
Week 8.  Given that Poisson regression requires count data (integer scores) as input, raw scores 
from Week 1, Week 4, and Week 8 were used in these analyses rather than the mean item scores 
used in prior analyses using weekly data as a unit of measurement.  Hence the dependent 
variable was mood/motivation and vegetative scores that were measured along the independent 
variable- Weeks.  
The results of the regression are shown in Table 4. The top portion of the table shows the 
results from the analysis of mood/motivation scores.  The Poisson regression equation indicated 
that participants’ scores were best predicted by the following regression equation: 4.40 - 
.35(week).  That is, to predict an individual’s score at any given week, .35 times the number of 
weeks since the beginning of treatment would be subtracted from 4.40.  For example, to predict a 
person’s score in Week 5, the regression equation would be 4.40 - .35(4) = 4.40 – 1.40 = 3.00.  
The average weekly reduction of .35 points was statistically significant, Wald(1) = 28.77, p < 




 The results for the Poisson regression analysis on vegetative scores are shown in 
the bottom section of Table 4.  The regression equation for vegetative scores was 4.56 - 
.30(week). Thus, the estimate of a person’s score at week 8 would be 4.56 – .30(7) = 4.56 – 2.1 = 
2.46. The average weekly reduction of .30 points was statistically significant, Wald(1) = 21.86, p 
< .001, indicating an overall significant reduction in vegetative symptoms over 8 weeks. In 
summary, for both mood/motivation scores and for vegetative scores, there was a statistically 
significant weekly decrease according to the Poisson regression analysis.  The average reduction 




Results from Poisson Regression Analyses on Mood/Motivation Symptoms and Vegetative 
Symptoms for Weeks 1, 4, and 8 
      
 B SEB Wald Df P 
      
      
Mood/Motivation Symptoms      
      
Intercept 4.40 .53 69.50 1 <.001 
      
Week -.35 .07 28.77 1 <.001 
      
Vegetative Symptoms      
      
Intercept 4.56 .53 74.47 1 <.001 
      
Week -.30 .06 21.86 1 <.001 
      
      
Note. For the Poisson model on mood/ motivation scores, Quasi-likelihood under independence 
model criterion (QIC) = .93; Correct quasi-likelihood under independence model criterion 




The second analysis for the first hypothesis was a curve estimate procedure conducted to 
explore the pattern of improvement of both the mood/motivation and vegetative symptoms over 
8 weeks as well as to test for the assumption of linearity of the data.  Curve estimation was 
computed separately for mood/motivation scores and for vegetative scores.  Table 5 shows the 
results from the analyses with mood/motivation scores as the dependent variable in the top 
section of the table and vegetative scores as the dependent variable in the bottom section of the 
table.  As with the Poisson analysis, scores from Weeks 1, 4, and 8 were included in the Curve 
estimation procedures, however instead of raw scores used for the Poisson analysis, mean item 
scores were used in the Curve estimation analysis. This is because Curve estimation can 
accommodate non-integer values.   
 
Table 5 
Results from Curve Estimate Analyses on Mood/Motivation Symptoms and Vegetative Symptoms 
for Weeks 1, 4, and 8 
      
 B SEB β t P 
      
      
Mood/Motivation Symptoms      
      
Constant .50 .08  6.13 <.001 
      
Linear  -.05 .01 -.36 -3.23 .002 
      
Quadratic -.01 .01 -.09 -.85 .400 
      
Vegetative Symptoms      
      
Constant .81 .11  7.51 <.001 
      
Linear  -.05 .02 -.29 -2.63 .011 




Quadratic -.02 .01 -.20 -1.83 .072 
      
      
Note. For mood/motivation symptoms, R2 for linear term = .13, F(1, 70) = 10.60, p = .002; 
increase in R2 with the addition of the quadratic term = .01; overall R2 for complete model = .14, 
F(2, 69) = 5.64, p = .005. For vegetative symptoms, R2 for linear term = .09, F(1, 70) = 6.90, p 
= .011; increase in R2 with the addition of the quadratic term = .04; overall R2 for complete 
model = .13, F(2, 69) = 5.24, p = .008. 
Table 6 
 For mood/motivation symptoms, the R2 for linear term was .13, F(1, 70) = 10.60, p = 
.002.  A quadratic term was added to test for the existence of a non-linear relationship between 
mood/motivation symptom improvement and time, given the possibility that mood/motivation 
(and vegetative symptoms) may fluctuate in response to the preventive treatment prior to 
improving. However, the addition of the quadratic term increased the R2 to .14, F(2, 69), = 5.64, 
p = .005, for an addition of only .01 in the R2 value.  The linear effect was statistically 
significant, B = -.36, p = .002, indicating that mood scores decreased by .36 points per week.  
The quadratic effect was not statistically significant, B = -.09, p = .400, indicating that the linear 
term was sufficient in explaining the decrease in mood/motivation scores. Hence the pattern of 
mood symptom improvement over 8 weeks was found to decrease at a steady pace. 
 In the analysis of vegetative symptoms, shown in the second part of Table 7, the linear 
term R2 was .09, F(1, 70) = 6.90, p = .011, indicating that the linear effect explained 9% of the 
variance in vegetative symptom scores.  Again, a quadratic term was added to test for non-
linearity in the relationship between vegetative symptom improvements over time. When the 
quadratic term was added, the R2 increased to .13, F(2, 69) = 5.24, p = .008, for an increase of 
.04.  However, while the linear term was statistically significant, B = -.29, p = .011, the quadratic 




changes in vegetative symptom scores, with a decrease of .29 points per week, pointing to a 
stable decrease of vegetative symptoms over time.  
Since a determination of overall significance of mood/motivation and vegetative 
symptoms, and a linear relationship of the two clusters over time was found through the Poisson 
regression and Curve Estimation procedure, we wanted to examine differences in symptom 
improvement between mood/motivation and vegetative scores using graphical analysis.   
Mood/ motivation scores were plotted with vegetative scores in a line graph.  The graph 
compared changes in mood/motivation scores with changes in vegetative scores to determine if 
there is a trend toward one or the other type of depressive symptom showing improvement first.  
In addition to examining the weekly scores in various sections of this chapter, each pair of weeks 
was combined into what will be referred to as “Time” scores for other analyses.  Weeks 1 and 2 
scores were combined into Time 1, Weeks 3 and 4 scores were combined into Time 2 and so on.  
As discussed earlier, the conversion of weekly data into biweekly data was done by combining 
each pair of weeks to increase the data available for various analyses.  Table 6 shows the mean 
scores for mood/motivation symptoms and vegetative symptoms for these four time points, and 
Figure 1 shows a line graph of these means.  
Referring to the data in Table 6, the decrease from Time 1 to Time 2 for mood/ 
motivation symptoms averaged .10, while the decrease for vegetative symptoms for this time 
period was only .02, indicating that mood/motivation symptoms decreased more rapidly than 
vegetative symptoms.  The decrease from Time 2 to Time 3 was slightly larger for vegetative 
symptoms than for mood/motivation symptoms, with an average decrease of .04 for 
mood/motivation symptoms and .09 for vegetative symptoms.  From Time 3 to Time 4, the 




.20 for vegetative symptoms.  Overall, vegetative symptoms had an average decrease of .31 
compared to an average decrease of .24 for mood/motivation symptoms, but the 




Descriptive Statistics for Mood and Motivation and Vegetative Symptoms as a Function of Time 
Point 
     
 Mood and Motivation Vegetative 
     
Time Point M SD M SD 
     
     
Time 1 .55 .32 .74 .48 
     
Time 2 .45 .34 .72 .51 
     
Time 3 .41 .39 .63 .45 
     
Time 4 .31 .31 .43 .40 
     





Figure 1. Mood/motivation and vegetative symptoms as a function of time point.  
 Since differences in the rate of improvement within the mood/motivation and vegetative 
clusters were observed in the graphical analysis at different time points, the first hypothesis of 
this study also included an examination of changes separately for mood/motivation symptoms 
and for vegetative symptoms.  Paired samples t tests were considered appropriate for comparing 
successive mood/motivation scores and successive vegetative scores to look for within cluster 
differences given the small sample size of the current study.   For Time 1 to Time 2 changes in 
mood/motivation scores, the difference was statistically significant, t(26) = 2.45, p = .021, but 
changes for the same time period for vegetative symptoms scores were not statistically 
significant, t(26) = 1.90, p = .068.  This indicated that mood/motivation scores decreased 
immediately, while vegetative symptoms scores did not decrease significantly across the first 
















 The change from Time 2 to Time 3 for mood/motivation scores was not statistically 
significant, t(26) = 1.20, p = .242, and the same was true for change for vegetative scores, t(26) 
= .68, p = .500.  This indicated that neither mood/motivation scores nor vegetative scores 
decreased significantly during the middle time period.  The Time 3 to Time 4 change for 
mood/motivation scores was not statistically significant, t(27) = 1.52, p = .141, but change over 
this same time period for vegetative symptom scores did reach a level of statistical significance, 
t(27) = 2.88, p = .008.  Thus, vegetative symptoms scores decreased significantly over the final 
time period whereas mood/ motivation scores did not.  Finally, the comparison of Time 1 to 
Time 4 mood/motivation scores was statistically significant, t(25) = 3.60, p = .001, as was the 
Time 1 to Time 4 change for vegetative symptom scores, t(25) = 4.42, p < .001.  Thus, for both 
mood/ motivation scores and for vegetative scores, the decrease from the initial time point to the 
final time point was statistically significant.   
 The fifth method for examining the first hypothesis of this study was to conduct t tests in 
order to look more closely at between cluster differences at Time 2-Time 1, Time 3-Time 2, 
Time 4-Time 3 and Time 4-Time 1 for mood and vegetative symptoms. Difference scores were 
computed representing the Time 1 to Time 2 difference, the Time 2 to Time 3 difference, the 
Time 3 to Time 4 difference, and the Time 1 to Time 4 difference. The paired samples t test 
comparing the Time 1 to Time 2 difference for the two types of symptoms was not statistically 
significant, t(26) = .32, p = .752, indicating that the decrease in score from Time 1 to Time 2 was 
not different for mood/motivation symptoms versus vegetative symptoms. Similarly, there was 
no difference between the change in scores between mood/motivation symptoms and vegetative 




.282.  However, mood/motivation scores were significantly lower than the vegetative scores for 
Time 3 to Time 4, (M = .05, SD = .25), t(24) = -2.52, p = .019. 
 The final set of analyses for the first hypothesis consisted of a repeated-measures 
ANOVA to examine within-cluster differences across the four time points separately for 
mood/motivation symptoms and for vegetative symptoms.  The repeated -measures ANOVA was 
possibly the most appropriate test to conduct the analysis of hypothesis 1; however there was 
also the possibility of finding non-significant results due to our small sample size. Hence, after 
the paired sample t-tests revealed significant differences between the rate of decrease of 
mood/motivation and vegetative symptoms, we wanted to test the robustness of our conclusions 
using a more statistically stringent test such as the repeated-measures ANOVA. The test revealed 
that for mood symptoms, the overall change from Time 1 to Time 2, to Time 3, and to Time 4 
was statistically significant, F(3, 66) = 7.77, p < .001.  This indicated that mood/motivation 
scores across the four time points were significantly different.   
In order to determine which time points differed from which others, planned contrasts 
were performed comparing each time point to the next.  The results from the contrast tests 
indicated that Time 2 mood/motivation scores (M = .44, SD = .35) were significantly lower than 
Time 1 scores (M = .57, SD = .32), F(1, 22) = 5.09, p = .034.  Similarly, Time 3 scores (M = 
.36, SD = .37) were significantly lower than Time 2 scores, F(1, 22) = 6.21, p = .021, and Time 
4 scores (M = .29, SD = 29) were significantly lower than Time 3 scores, F(1, 22) = 12.37, p = 
.002.  The means for the repeated-measures analysis differ somewhat from the means presented 
above in Table 6 because only participants with all scores at all four time points were included in 




 In terms of the analysis performed on vegetative scores, the overall change across Time 
1, Time 2, Time 3, and Time 4 was statistically significant, F(3, 66) = 6.68, p = .001, indicating 
that scores across the four time points differed. Follow up contrasts indicated that for vegetative 
symptoms, the scores for Time 2 (M = .65, SD = .49) did not differ from the scores from Time 1 
(M = 77, SD = .50), F(1, 22) = 2.94, p = .101.  Similarly, the scores from Time 3 (M = .63, SD 
= .48) did not differ from the scores from Time 2, F(1, 22) = 1.26, p = .274.  However, scores 
from Time 4 (M = .44, SD = .44) were found to be significantly lower than scores from Time 3, 
F(1, 22) = 16.17, p = .001. The results from this analysis of vegetative scores indicated that 
statistically significant change did not occur until the Time 3 to Time 4 period.  
 The finding for vegetative scores from the repeated-measures ANOVA may appear 
somewhat contradictory to the results from the Poisson regression, in that the ANOVA shows a 
significant decrease for vegetative symptoms only at Time 4, whereas the Poisson results 
indicate that the average reduction in vegetative symptoms over eight weeks as significant.  
However, it is important to note that the Poisson procedure (unlike the ANOVA) does not test 
each individual time point for statistical significance; rather the overall change is tested.  Thus, 
the repeated-measures ANOVA indicated that there was no change in vegetative symptoms 
scores until the fourth time point, and the Poisson procedure demonstrated that the average 
weekly change, overall, was statistically significant. Hence these two tests do not have 
comparable conclusions. 
One of the prominent depression outcome criteria is response and its operationalization 
as a 50% reduction in depressive symptomatology score continues to be widely used as an 
outcome measure in both psychotherapy and antidepressant medication treatment trials (e.g., 




al., 2007; Zarate et al., 2006).  Similar to the analysis conducted by Worthington et al. (1995), 
where participants were identified as having a full response (defined as having a greater than or 
equal to 75% improvement from baseline score during the first four weeks of treatment and 
maintained until the end), early partial improvement (defined as greater than or equal to 50% 
improvement from baseline score occurring during the first four weeks of treatment), and late 
complete improvement (defined as greater than or equal to 75% improvement from baseline 
score occurring during the last four weeks of treatment), a supplemental set of analyses was 
performed to examine early and late responders to treatment in this study using a 50% 
improvement threshold.   
Categories of improvement created and analyzed in this study were defined as early 
sustained change, early unsustained change, late change and no change.  A participant classified 
in the early sustained change category was a participant who showed a 50% reduction in 
symptoms by Week 4 and at Week 8. A participant classified in the early unsustained change 
category was a participant who showed improvement at Week 4 but not at Week 8.  A participant 
classified in the late change category was a participant who showed a 50% reduction in 
symptoms by Week 8.  A participant classified in the no change category was a participant who 
showed less than 50 % reduction in symptoms at Week 4 and at Week 8.  In order to account for 
missing data, scores from Week 2 were imputed for missing data at Week 1.  Similarly, scores 
were imputed from Weeks 3 and 7 for those subjects missing data at Weeks 4 and 8, 
respectively.  The imputation of scores was necessary to determine percent reductions in the 
current classification analysis, but was not necessary and therefore not performed for the other 




 Table 7 shows the percentage of participants falling into each of the categories defined 
above in terms of their mood/motivation symptoms.  With reference to Table 7, one-quarter of 
the participants (25.0%) experienced early change (by Week 4) that was sustained through Week 
8. Nearly one-third of the participants (31.3%) experienced late change by Week 8 but not early 
change by Week 4, and this was the largest group of participants.  An additional 6.3% of the 
participants experienced early change by Week 4 that was not sustained through Week 8, while 
12.5% of the participants experienced no change at either Week 4 or Week 8.  The remaining 
participants did not have data at all three time points.  This included 6.3% of the participants who 
did not have Week 8 data and had not improved by Week 4, 3.1% of the participants who had no 
Week 4 data but had improved by Week 8, and 3.1% of the participants who had no Week 4 data 
and had not improved by Week 8.  The remaining 12.5% of the participants had insufficient data 
for this analysis.  
 
Table 7 
Analysis of Categories of Improvement of Mood/Motivation Symptoms 
   
Group Frequency Percentage 
   
   
Early sustained change 8 25.0 
   
Early unsustained change 2 6.3 
   
Late change 10 31.3 
   
No change 4 12.5 
   
No data at midpoint, late change 1 3.1 
   




   
Group Frequency Percentage 
   
   
   
No change at midpoint, no data at end 2 6.3 
   
Missing data 4 12.5 
   
   
 
Table 8 shows the percentage of participants falling into each of the categories defined 
above in terms of their vegetative symptoms.  In this group, 15.6% of the participants 
experienced early change (by Week 4) that was sustained through Week 8.  Similar to 
participants in the mood/motivation improvement category, 6.3% of the participants experienced 
early change in vegetative symptoms by Week 4 that was not sustained through Week 8.  The 
two largest groups in this category were the participants who experienced late change by Week 8 
but not early change by Week 4 (25.0%), and the no change group (25.0%) who experienced no 
change at either Week 4 or Week 8.  The remaining participants did not have data at all three 
time points.  This included 6.3% of the participants who did not have Week 4 data and had not 
improved by Week 8, 3.1% of the participants who had improved by Week 4 but who had no 
Week 8 data, and 3.1% of the participants who had not improved by Week 4 data and had no 









Analysis of Categories of Improvement of Vegetative Symptoms 
   
Group Frequency Percentage 
   
   
Early sustained change 5 15.6 
   
Early unsustained change 2 6.3 
   
Late change 8 25.0 
   
No change 8 25.0 
   
No change at midpoint, no data at end 1 3.1 
   
No data at midpoint, no late change 2 6.3 
   
Change at midpoint, no data at end 1 3.1 
   
Missing data 5 15.6 
   
   
 
Hypothesis 2 
Hypothesis 2 of this study was that controlling for baseline severity of symptoms, 
adolescents who show improvements in mood/motivation symptoms would also show 
improvements in vegetative symptoms, as measured by the depression symptom checklist.  The 
rationale for this hypothesis was that given the participants in the study were experiencing 
subthreshold depressive symptoms; there would not be much difference in terms of those 
participants who improved on mood symptoms and the participants who improved on vegetative 




participants of our study, we would not find significant variance in subjects’ improvement 
pattern on the two clusters.  
In order to test this hypothesis, the difference between the Time 4 scores (the average of 
Week 7 and Week 8 data) and the Time 1 scores (the average of Week 1 and Week 2 data) were 
computed for each subject for the mood/motivation score and the vegetative score.  Then, the 
partial correlation between changes in mood/motivation scores and changes in vegetative scores 
were computed. Both bivariate (Pearson) correlations and partial correlations (controlling for 
baseline depression scores on both the mood/motivation scale and the vegetative scale) were 




Descriptive Statistics for Scores for Partial Correlation Analysis 
     
 Minimum Maximum M SD 
     
     
Mood/Motivation Time 1 .00 1.33 .55 .32 
     
Vegetative Time 1 .10 1.80 .74 .48 
     
Mood/Motivation Change -1.08 .67 -.25 .35 
     
Vegetative Change -1.00 .20 -.33 .38 
     
     
 
The Pearson correlation between changes in mood/motivation scores and changes in 
vegetative scores was found to be significant, r = .48, p = .013.  This indicated that changes in 




the partial correlation between changes in mood/ motivation scores and changes in vegetative 
scores controlling for Time 1 scores on both scales was not statistically significant, r = .37, p = 
.108.  This indicated that changes in mood/motivation scores were not significantly correlated 
with changes in vegetative scores when controlling for baseline levels of mood/motivation scores 
and vegetative scores. Put another way, these results indicate that there is a difference in the 
association of mood symptom improvement and vegetative symptom improvement across 
different levels of depression. 
 
Exploratory Analyses 
Given that this dissertation attempted to shed light on a process not previously examined, 
specifically with regards to adolescent symptom improvement, we wanted to conduct other 
analyses in addition to the hypotheses presented above. We believed that these analyses would 
further our understanding of the relationship of moderator variables such as gender and treatment 
condition, but also reveal important information regarding the relationship between 
mood/motivation, vegetative and total depression symptoms at baseline and at the end of the 
treatment. 
Exploratory 1: The first exploratory analysis was an examination of gender differences.  
Although the Young, Mufson, & Gallop (2010) had looked at pertinent differences between 
subjects (including gender), at baseline, sex of participants had not been examined as a 
moderator variable in the study.  
Hence, a multivariate analysis of variance (MANOVA) was conducted including 
mood/motivation scores and vegetative scores from Times 1, 2, 3, and 4 as dependent variables.  




Overall, the effect of gender on the dependent variables was not statistically significant, 
F(2, 20) = 2.28, p = .127, indicating that males and females did not differ.  However, the main 
effect for time was statistically significant, F(6, 16) = 4.30, p = .009.  This indicated that scores 
from Time 1, Time 2, Time 3, and Time 4 were not equivalent, as demonstrated in prior 
analyses.  The interaction between gender and time was not statistically significant, F(6, 16) = 
.509, p = .793.  This indicated that the effect of time was the same for males and females.  Due 
to the fact that gender was not statistically significant in prior analyses, follow-up tests were not 
performed. 
Exploratory 2: A second set of exploratory analyses was conducted comparing 
conditions.  This analysis was felt necessary as the Young, Mufson, & Gallop (2010) had found 
significant differences between the AST (without parental involvement) and ENH (with parental 
involvement) conditions, with the ENH condition reporting lower post-intervention depression 
scores than the AST group. However, as mentioned in the results section, due to randomization 
issues, no significant conclusions could be drawn from these findings.  
A MANOVA was performed with mood/motivation scores at Times 1, 2, 3, and 4 and 
vegetative scores at Times 1, 2, 3, and 4 as the dependent variables.  The independent variable 
was condition: AST versus ENH.  The main effect for condition was found to be statistically 
significant, F(2, 20) =  4.41, p= .026 indicating that participants in the two conditions AST and 
ENH differed significantly in terms of their improvement on the mood/motivation and vegetative 
clusters.  Follow up univariate tests using a Bonferroni correction indicated that the effect of 
condition was statistically significant for mood/motivation symptoms, F(1, 21) = 5.60, p = .028, 
but was not statistically significant for vegetative symptoms, F(1, 21) = .13, p = .726. This 




not for vegetative symptoms.   The mood/ motivation symptom means of the AST group were 
larger, averaging .51 (SD = .05) across times, while the ENH group averaged .24 (SD = .06) 
across times showing that the ENH group fared better in terms of their mood/motivation 
symptoms.  For vegetative symptoms, no differences emerged and the two means were not 
statistically different: M = .60 (SD = .08) for the AST group and M = .67 (SD = .11) for the 
ENH group.  
The main effect for time was statistically significant, F(6, 16) = 5.36, p = .003 showing 
that there were significant differences between mood/motivation symptom improvement and 
vegetative symptom improvement regardless of condition. Follow up tests were performed using 
a Bonferroni adjustment to compare each pair of times separately for mood/motivation 
symptoms and for vegetative symptoms.   
For mood/motivation symptoms, Time 1 scores (M = .56, SD = .05) were significantly 
higher than Time 2 scores (M = .39, SD = .05), p = .047, Time 3 scores (M = .31, SD = .05), p = 
.009, and Time 4 scores (M = .25, SD = .04), p = .001.  The other pairs of consecutive time 
points (e.g., Time 2 versus Time 3) did not differ in these analyses despite the fact that they 
differed in the prior analyses due to the use of the conservative Bonferroni adjustment in the 
follow up tests for the MANOVA.  
For vegetative scores, Time 4 scores (M = .41, SD = .07) were significantly lower than 
Time 1 scores (M = .79, SD = .08), p = .001, Time 2 scores (M = .69, SD = .07), p = .014, and 
from Time 3 scores (M = .64, SD = .08), p = .017.  Thus it can be concluded from these results 




indicating early improvement, whereas for vegetative symptoms, the last time point differed 
from all earlier time points, indicating late improvement.   
The interaction between condition and time was not statistically significant, F(6, 16) = 
1.16, p = .373, indicating that the effect of time was the same for the two conditions. Participants 
in the two conditions do not change differentially over time. 
Exploratory 3: Another exploratory aim of the study was to examine the category of 
participants who showed no improvement on the two clusters through the eight time points. The 
reason for conducting this analysis was to see what pattern would emerge for these participants 
who possibly did not benefit from the IPT-AST preventive treatment. Those subjects whose final 
(week 8) score of mood motivation, and vegetative symptoms were no lower than their initial 
(week 1) score on mood/motivation, and vegetative symptoms were identified and their scores 
across the eight time points were plotted separately on a line graph.   
Since data from all 8 weeks were included in the analysis, imputations were used to work 
with any missing data, where if a subject was missing a score at week 1, their score from week 2 
was substituted.  Similarly, if their score at week 8 was missing, then their score at week 7 was 
imputed. For subjects who may have missing data at both weeks, Maximum Likelihood 
Estimation was used to provide estimates that would most likely have resulted in the data that 
was missing.  Figure 2 shows the scores of participants who had no improvement on 
mood/motivation symptoms and Figure 3 indicates the scores of participants who had no 





Figure 2. No improvement scores on Mood/ motivation symptoms as a function of weeks.  
 The graph in Figure 2 demonstrates that four participants were classified as having not 
improved on the basis of the difference between their week 8 and week 1 mood/motivation 
scores. Of these four participants, at least two subjects can be identified as having a more 
dramatic increase in the mood/motivation symptoms closer at week 8. Hence it appears that IPT-
AST preventive treatment may not benefit all adolescents with sub-threshold depression in terms 



















Figure 3. No improvement scores on Vegetative symptoms as a function of weeks.  
The graphs in Figure 3 demonstrate that seven participants were classified as having not 
improved on the basis of the difference between their week 8 and week 1 vegetative scores. In 
comparison to the subjects who did not improve on their mood/motivation symptoms, more 
participants did not improve in terms of their vegetative symptoms. Three participants identified 
as having not improved on this graph were also observed to not improve on the previous graph 
demonstrating that some subjects did not improve on both categories.  The results from these two 
figures also indicate that subjects whose mood/motivation symptoms did not improve, may also 
not improve on their vegetative symptoms, but subjects who don’t improve on vegetative 
symptoms may experience an improvement in their mood/motivation symptoms.  
Exploratory 4: An additional supplemental analysis was performed to determine if there 
was a relationship between improvements in vegetative or mood symptoms and improvement in 





















order to test these relationships, correlations were computed between improvement in overall 
depression scores (Time 4 scores – Time 1 scores) and improvement in mood/motivation scores 
(Time 4 scores – Time 1 scores) and improvement in vegetative scores (Time 4 scores – Time 1 
scores). 
Table 10 shows these correlations. Changes in mood/motivation scores were positively 
correlated with changes in vegetative scores, r = .47, p = .013.  Changes in mood/motivation 
scores were highly, positively correlated with total depression changes, r = .87, p < .001, and 
changes in vegetative scores were also positively correlated with total depression changes, r = 
.84, p < .001. Hence, over the four time points, subjects who improved on mood symptoms also 
improved on vegetative symptoms and total depression symptoms. Conversely, subjects who 
improved on vegetative symptoms also improved on mood symptoms and total depression 
symptoms. Therefore, improvements in all forms of depressive symptoms were positively 
correlated with changes in other forms of depressive symptoms as well. 
 
Table 10 
Correlations Among Mood/Motivation, Vegetative, and Total Change Scores 









    
    
Mood/motivation Change 1.00   
    
Vegetative Change .47* 1.00  
    
Total Depression Change .87** .84** 1.00 




    
*p<.05. **p<.001 
 
Exploratory 5: We were also interested in examining the correlations between changes in 
scores for mood/motivation, vegetative and total depression symptoms at Time 1, to determine 
whether or not people who have elevated scores on mood/motivation at baseline are the same as 
those who have elevated scores on vegetative symptoms at baseline.  Table 11 shows the 
correlations among Time 1 scores on the three scales. Results indicated that mood/motivation 
scores were positively correlated with vegetative scores at Time 1 (r = .43, p = .020), and 
positively correlated with total depression scores at Time 1 (r = .81, p < .001).  In addition 
vegetative scores were positively correlated with total depression scores at Time 1 (r = .88, p < 
.001). This indicates that those subjects who had high mood symptoms at baseline also tended to 
have high vegetative symptoms at baseline and conversely, those subjects who had low mood 
symptoms at baseline also tended to have low vegetative symptoms at baseline. 
 
Table 11 
Correlations Among Mood/ Motivation, Vegetative, and Total Scores at Time 1 
    
 Mood/motivation Vegetative Total 
Depression  
    
    
Mood/Motivation 1.00   
    
Vegetative .43* 1.00  
    
Total Depression .81** .88* 1.00 
    
    





Exploratory 6: It was also of interest to determine if baseline (Time 1) total depression 
scores were related to mood/motivation scores and vegetative scores at later time points (Times 
2, 3, and 4). Results shown in Table 12 were indicative that baseline total depression scores were 
positively correlated with Time 2, 3, and 4 vegetative scores, but not significantly related to 
Time 2, 3, or 4 mood and motivation scores. These results convey that the more depressed a 
subject was at baseline was strongly related to how many vegetative symptoms they had later on 
but not to how many mood/motivation symptoms they had later on. Put another way, subjects 
who had higher total depression symptoms in the beginning tended to have greater vegetative 
symptoms later on but not greater mood/motivation symptoms. 
 
Table 12 
Correlations Among Baseline Total Depression Scores and Mood/motivation and Vegetative 






Mood/ Motivation  
  
Time 2 .34 
  
Time 3 .27 
  




Time 2 .73* 
  










Exploratory 7: An additional set of analyses were performed to determine if participants 
who had the most elevated levels of total depression at baseline also had elevated 
mood/motivation and vegetative depression scores at baseline.  In order to categorize participants 
as elevated or non-elevated, median splits were performed on total depression scores, 
mood/motivation scores, and vegetative scores at Time 1. The median score for mood/motivation 
symptoms was determined to be .42, the median score for vegetative symptoms was determined 
to be .70 and the median score for total depression symptoms was determined to be .55. Table 13 
shows the crosstabulations of total depression group with group membership on the 
mood/motivation and vegetative scores.  Of the participants with elevated total depression 
scores, 63.6% also had elevated mood/motivation scores, while only 38.9% of those without 
elevated total depression scores had elevated mood/motivation scores, however the relationship 
between elevations on total depression and mood/motivation was not statistically significant, 
χ2(1) = 1.68, p = .196.  Of the participants with elevated total depression scores, 100.0% also had 
elevated vegetative scores, while only 22.2% of those without elevated total depression scores 
had elevated vegetative scores.  This relationship was found to be statistically significant, χ2(1) = 
16.54, p < .001.  Hence it can be concluded that elevations in total depression are related to 
elevations in vegetative symptoms but not to elevations in mood/motivation symptoms. These 








Crosstabulation Between Elevations in Total Depression with Elevations in Mood/Motivation 
and Vegetative Scores at Time 1 
    
 Total Depression  
    
 Not Elevated Elevated Total Sample 
    
    
Mood/Motivation    
    
Not Elevated 11 (61.1%) 4 (36.4%) 15 (51.7%) 
    
Elevated 7 (38.9%) 7 (63.6%) 14 (48.3%) 
    
    
Vegetative    
    
Not Elevated 14 (77.8%) 0 (0.0%) 14 (48.3%) 
    
Elevated 4 (22.2%) 11 (100.0%) 15 (51.7%) 
    
    
Total Sample 18 (100.0%) 11 (100.0%) 29 (100.0%) 
    
 
Exploratory 8: The final set of exploratory analyses was conducted to determine if 
baseline scores on mood/motivation symptoms or vegetative symptoms were related to end-point 
total depression scores.  Like the previous exploratory analysis, a median split was performed for 
mood/motivation symptom scores and for vegetative symptoms scores at baseline (Time 1) to 




two-factor ANOVA was conducted as we had two independent variables with two levels: 
mood/motivation (high or low) baseline group and vegetative (high or low) baseline group. Total 
depression scores at Time 4 was entered as the dependent variable.  
 
Table 14 
Average Time 4 Total Depression Scores as a Function of Level of baseline Mood/motivation 
and Vegetative Scores 
     
 Low Baseline Mood/ 
Motivation Symptoms 
(n = 13) 
High Baseline Mood/ 
Motivation Symptoms 
(n = 13) 
     
 M SD M SD 
     
     
Low Baseline Vegetative 
Symptoms (n = 13) 
.27 .11 .41 .21 
     
High Baseline Vegetative 
Symptoms (n = 13) 
.26 .13 .56 .48 
     
     
 
Table 14 shows the mean Time 4 total depression scores as a function of group 
membership on the baseline mood/motivation and vegetative groups.  The main effect for 
baseline mood/motivation group was not statistically significant, F(1, 22) = 3.91, p = .061, and 
the main effect for baseline vegetative group was not statistically significant, F(1, 22) = .37, p = 
.550.  In addition, the interaction between baseline mood/motivation group and baseline 
vegetative group was also not statistically significant, F(1, 22) = .55, p = .465.  Thus, baseline 




depression scores in the final period of data collection, which indicates that clinical presentation 
of a subject did not determine what happened to them at the end of the preventive treatment.  
 
Summary of Findings 
The first hypothesis of this study was that improvements in mood/motivation will precede 
improvements in vegetative symptoms.  This hypothesis was supported by several of the findings 
from this study.  First, the graphical analysis showed that the initial decrease in mood/motivation 
scores was larger (averaging .10 points) than the initial decrease in vegetative symptom scores 
(averaging .02 points).  While the overall decrease in symptom scores across the duration of the 
study was similar for the two types of depressive symptoms, the graphical analysis indicated that 
mood/motivation symptoms decreased more quickly, with most of the decrease in vegetative 
symptoms occurring near the end of the 8 week period of this study.   
 The second source of support for the first hypothesis of this study came from the paired 
samples t tests were performed comparing successive mood/motivation scores and successive 
vegetative scores separately.  The Time 1 to Time 2 decrease in mood/motivation scores was 
statistically significant, while the Time 1 to Time 2 decrease in vegetative scores was not.  This 
indicated that mood/motivation scores decreased immediately, while vegetative symptoms scores 
did not.  From this analysis, the change in both mood/motivation scores and vegetative scores 
during the middle time period was not statistically significant, but vegetative scores decreased 
significantly through the final time period while mood/motivation scores did not.  Again, these 
analyses indicated that mood/motivation scores decreased during the initial time period while 




 Third, the repeated-measures ANOVA analysis indicated that mood/motivation scores 
decreased significantly from Time 1 to Time 2, while vegetative scores did not. For vegetative 
symptoms, the statistically significant decrease in scores did not occur until the Time 3 to Time 4 
period.  In addition, while not a planned procedure for testing the first hypothesis of this study, 
the MANOVA performed to compare treatment conditions indicated that for mood/motivation 
symptoms, the earliest time point differed from all later time points, indicating early 
improvement, whereas for vegetative symptoms, the last time point differed from all earlier time 
points, indicating late improvement.  It should be noted that despite these sources of support for 
the first hypothesis of this study, the comparisons between mood/motivation scores and 
vegetative scores at each time point, the Poisson regression analysis, and the curve estimate 
procedures did not provide support for the first hypothesis of this study.  
 The second hypothesis of this study was that controlling for baseline severity of 
symptoms, adolescents who show improvements in mood/motivation symptoms would also 
show improvements in vegetative symptoms.  While the Pearson (bivariate) correlation between 
improvements in mood/motivation symptoms and improvements in vegetative symptoms was 
statistically significant, the partial correlation was not statistically significant.  This indicated that 
changes in mood/motivation scores were not significantly correlated with changes in vegetative 
scores when controlling for baseline levels of mood/motivation scores and vegetative scores, and 
therefore the second hypothesis of this study was not supported.  
In addition to the planned hypothesis tests, supplemental and exploratory analyses were 
performed. These analyses produced the following findings:  
1. For mood/motivation symptom improvement, the two largest groups of participants were 




indicating the efficacy of the treatments due to the fact that most of the participants 
experienced a 50% reduction in mood/motivation symptoms at some point during the 
study.  For vegetative symptom improvement, a large group of participants experienced 
late change (25.0%) indicating that vegetative symptoms respond closer towards the end 
of treatment.  
2. Males and females did not differ in their levels of symptoms or improvement throughout 
the 8 weeks of the study.  
3. Participants in the AST group tended to have more mood/motivation symptoms than 
those in the ENH group, but the two groups did not differ in terms of vegetative 
symptoms, and there was no difference in changes in symptom scores (for either 
mood/motivation or vegetative symptoms) for the two conditions.  
4. An analysis of the relationship between reduction in vegetative or mood/motivation 
symptoms and improvement in overall depressive symptoms indicated that changes in 
mood/motivation scores were positively correlated with changes in vegetative scores, that 
changes in mood/motivation scores were positively correlated with total depression 
changes, and that changes in vegetative scores were positively correlated with total 
depression changes.  
5. Participants with high baseline scores on the mood/motivation scale also tended to have 
high baseline scores on the vegetative scale, and vice versa.  
6. Baseline total depression scores were related to subsequent scores on the vegetative scale 




7. Participants who had the most elevated baseline levels of total depression also tended to 
have elevated baseline vegetative scores but did not tend to have elevated baseline 
mood/motivation scores.  
8. Baseline mood/motivation group and baseline vegetative group were not significantly 
related to total depression scores in the final period of data collection.  
 
The next chapter presents a discussion of the results presented in this chapter in the 
context of past research.  In addition, the implications of these findings and recommendations for 








The primary aim of this study was to closely examine the responses of adolescents who 
completed the IPT-AST preventive treatment and look for any trends in their symptoms as they 
changed over the 8 weeks of treatment. It is believed that these trends would help the mental 
health community recognize symptom response to IPT-AST preventive treatment and be more 
aware of risks associated with symptom abatement following response to treatment.  This study 
included an examination of two types of symptoms commonly found in depression: 
mood/motivation symptoms such as sadness, hopelessness and guilt, and neurovegetative or 
physical symptoms such as sleep, appetite, and energy levels.  Based on the identification of 
knowledge gaps in the literature, two main research questions were developed.  
First, in looking at differences in patterns of mood/ motivation, and vegetative symptoms 
within the IPT-AST condition, which symptoms would improve faster—mood or vegetative?  
Second, controlling for baseline severity of symptoms, would adolescents who show 
improvements in one category of symptoms (mood/motivation or vegetative) also show 
improvements in the other category of symptoms?  The rationale for some of these research 
questions was presented earlier in the results section. 
For the first research question, it was predicted that improvements in mood/motivation 
symptoms would precede improvements in vegetative symptoms.  This hypothesis was 
confirmed by the analyses conducted to test for differences between the rates of improvement for 
the two clusters. Namely, the graphical analysis, paired sample t-tests which compared within 
cluster differences (successive mood/motivation scores and successive vegetative scores 




vegetative symptom scores at different time points), as well as the repeated-measures ANOVA 
demonstrated that mood/motivation symptoms of the adolescents tended to decline prior to the 
decline of their vegetative symptoms.  The results of the Poisson regression analysis and the 
curve estimate procedures were not used to provide direct support for the first hypothesis of this 
study, instead they were used to comment specifically on the nature of overall improvement of 
symptoms in the two categories which was found in order to support further investigation.   
Support for the first hypothesis also came from the MANOVA results that compared 
differences in symptom clusters (mood/motivation and vegetative) between the two conditions 
(AST and ENH).  When pairs of time points were compared separately for mood/motivation and 
vegetative symptoms, Time 1 scores were found to be significantly higher than Time 2, Time 3 
or Time 4 points.  Since the earliest time point differed from subsequent time points, it can be 
concluded that mood/motivation symptoms experienced an earlier change than vegetative 
symptoms, for which Time 4 scores were significantly different from Time 1, Time 2 and Time 3 
scores, indicating a later change. 
These results confirming the findings of hypothesis 1 are consistent with other studies 
identified in the literature. Rush et al’s., (1982) study which compared the effects of cognitive 
therapy and pharmacotherapy (imipramine hydrochloride) found that in response to cognitive 
therapy, symptoms of hopelessness, and mood symptoms improved prior to vegetative symptoms 
as well as our own pilot study which found that although non-significant, symptoms of 
mood/motivation tended to improve prior to vegetative symptoms, (Sinh et al.; unpublished).  
The second research question of the study had sought to examine whether improvement 
in one category of symptoms (mood/motivation or vegetative) accompanied improvement in the 




it was thought that due to the specific properties of our sample (small in size and exhibiting 
subthreshold symptoms), we would find associations in the improvement of symptoms in the two 
clusters when controlling for baseline levels of mood and vegetative symptoms.  However, this 
hypothesis was not confirmed by the study and partial correlations between mood/motivation and 
vegetative symptom improvement across different levels of depression were found to be non-
significant. Although these results did not support our hypothesis, it clarified that subjects with 
varying levels of depression at baseline, had differential improvement on their mood/motivation 
and vegetative symptoms over time. Clinically, it seemed reasonable for a distinction to exist 
between a person’s improvement on mood/motivation and vegetative symptoms, based on their 
presentation at baseline. However, since none of the literature reviewed included any analyses of 
associations of improvement controlling for certain variables, these findings should be viewed 
somewhat tentatively. 
Exploratory Analysis Results 
In addition to the two main research questions of this dissertation, exploratory analyses 
were also carried out with the purpose of making more clarifications regarding the role of 
variables such as gender of the participants in terms of their improvement. This study seemed 
relevant, as prior research has demonstrated the presence of modest gender-based differences in 
the presentation of depression of adolescents (Bennett, Ambrosini, Kudes, Metz, & Rabinovitz, 
2005). However, to our knowledge, gender-specific remittance of symptoms in adolescent boys 
and girls with subsyndromal depression has not been studied.  The current study also found no 
differences in symptom improvement on mood/motivation and vegetative scores over time 
indicating that males and females did not differ significantly in terms of their improvement on 




study used the depression symptom checklist which is a self-report measure.  Perhaps if another 
measure had been incorporated to corroborate the self-report screen or symptoms had been 
tracked by a clinician or obtained from parents, teachers or care-givers, we may have obtained 
data more sensitive to gender differences in improvement as was found in the Bennett, 
Ambrosini, Kudes, Metz, and Rabinovitz (2005) study noted earlier.  Another possible reason is 
that since symptoms endorsed on the depression symptom checklist were subclinical to begin 
with, the trajectory for improvement in symptoms did not have sufficient room to allow for 
significant differences to emerge between boys and girls in our study. 
The current study also explored the breakdown of mood/motivation symptoms and 
vegetative symptoms over time when the original IPT –AST vs. ENH treatment conditions were 
analyzed.  Although no differences were found between groups on vegetative symptoms, 
significant differences were found between the AST and ENH groups on mood/motivation 
symptoms. Specifically, the ENH group with parental involvement was found to outperform the 
AST group in terms of mood/motivation symptom improvement but not in terms of vegetative 
symptom improvement. Non-significant findings between conditions over time may have been 
due to the randomization issue of the two groups (noted earlier in Method section) which led 
them to being collapsed into one single IPT-AST group.  Given that the AST group had 
somewhat higher mean mood/motivation symptoms than the ENH group, it might be expected 
that some differences in the rate of mood/ motivation symptom changes between the two 
conditions may occur. It could be speculated that the rate of change of mood/motivation 
symptoms for the AST condition would be expected to be lower than the ENH group, although 
our results did not demonstrate this.  One explanation for the lack of difference in the rate of 




low average mood/motivation symptoms in the ENH group (.25 across times), indicative of a 
floor effect where there was little room for the mood/motivation symptoms to improve.  
Although prior studies reviewed had not conducted analyses of participants who did not 
respond to treatment, the current study investigated participants demonstrating no-improvement 
over the 8 weeks of treatment. The graphical analysis of the no-improvement group for both 
mood/motivation and vegetative symptoms did not reveal specific trends regarding individual 
adolescent trajectories.  For mood/motivation symptoms, all four subjects included as having not 
improved began treatment with relatively few mood/motivation symptoms (three) which could 
again indicate that they did not have much room for improvement to begin with.  However, at 
least two adolescents were noted to worsen significantly near the end of the data collection in 
Weeks 7 and 8 indicative of natural variability or the possibility that IPT-AST may not work for 
all adolescents.   
For vegetative symptoms, more subjects were identified as having not improved (7 as 
opposed to 4 in the mood/motivation cluster) with a majority of subjects listing between 0 to 2 
symptoms at Week 1.  However, there were no specific trends with regards to their lack of 
improvement.  It is also of note that only three subjects were common to both groups, indicating 
that approximately 90% of the participants improved according to the improvement criteria 
created for the purposes of this investigation.  These result also shows that participants who don’t 
improve on vegetative symptoms, may in fact improve in terms of their mood symptoms, 
however if mood symptoms do not demonstrate improvement, chances are that vegetative 





Relationship between baseline and end-point mood/motivation, vegetative, and total depression 
symptoms  
An exploration of the relationship between improvement in mood/motivation and 
vegetative symptoms and overall depression symptoms over time revealed that improvements in 
both mood/motivation and vegetative symptoms were associated with improvements in overall 
depressive symptoms.  Hence, mood improvements were related to total improvements, 
vegetative improvements were related to mood improvements, and both vegetative and mood 
improvements were related to total improvement. These results were in the expected direction 
since the formula used to compute overall depression was (mood/motivation + vegetative 
symptoms at week 1) - (mood/motivation + vegetative symptoms at week 8).  Therefore, it was 
to some extent a mathematical necessity that overall depression symptoms would be related to 
both mood/motivation symptom changes as well as vegetative symptom changes. These 
associations in improvement between symptoms in the two clusters  are consistent with results 
from Hypothesis 2, which also found the relationship between mood/motivation symptom 
change scores and vegetative symptom change scores to be significant (when not controlling for 
baseline mood/motivation and vegetative scores).   
From a clinical standpoint, we were interested in knowing whether adolescents who 
presented with high mood/motivation symptoms at baseline also presented with high vegetative 
symptoms at baseline.  Results tended to support our research question and adolescents who had 
high mood symptoms at Time 1 also tended to have high vegetative symptoms at Time 1.  These 
results are consistent with an epidemiological survey which showed that for adolescents with 
MDD, the most prevalent symptoms include depressed mood as well as sleep disturbances, and 




current study included participants with subclinical depressive symptoms and not symptoms 
severe enough to be in the range of MDD, it is interesting that similar trends were obtained in 
our study as were in the Roberts, Lewinsohn and Seeley (1995) paper mentioned above which 
included a sample of 1,710 adolescents (grades 9-12) from community high-schools. 
Additionally, given what is known about the risk of suicide being higher for patients who present 
with more affective symptoms than vegetative symptoms, or whose affective symptoms improve 
prior to their vegetative symptoms, these results may be protective of adolescents in terms of the 
risks associated with presenting with high affective and low vegetative symptoms.  
We were also curious about whether an initial clinical presentation corresponds to 
specific gains made in the treatment either in terms of mood/motivation improvement or 
vegetative symptom improvement. However, we did not find any evidence to support this idea, 
and an initial presentation of depression did not seem to affect mood/motivation scores, but 
instead had a greater impact on vegetative scores, such that the higher the baseline total 
depression scores, the higher were the vegetative scores later on. One conclusion of these 
findings is that vegetative symptoms were least responsive to the IPT-AST treatment of the 
study, than mood/motivation symptoms which is consistent with the findings of the “no-
improvement” groups. This however has further implications in terms of who is most likely to 
benefit from IPT-AST treatment. Our data showed this to be true for patients with more 
mood/motivation symptoms. 
When we studied whether a participant’s initial clinical presentation determined the 
direction of their improvement,  we hoped to find whether baseline severity of depression or how 
a subject who presents with a particular combination of symptoms (low mood- high vegetative, 




respond by the end of treatment.  Surprisingly, we found no relationship between initial 
presentation (baseline mood/motivation or vegetative symptoms) and treatment response on the 
basis of differential improvement on the two clusters. This finding was confusing as we had 
expected to find differences in improvement based on depression severity, especially since in a 
prior analysis we had found non-significant relationship between mood symptom improvement 
and vegetative symptom improvement controlling for baseline levels of depression. One 
plausible explanation for these results is that the dependent variable for the two-factor ANOVA 
used in the analysis was total depression scores from the checklist.  Perhaps if external endpoint 
scores from assessments such as the BDI or HAM-D had been used, a significant interaction 
between the independent (baseline mood and baseline vegetative) variables and dependent 
variable may have emerged. Similarly, using median splits to dichotomize participants as either 
elevated or non-elevated on the two clusters and on total depression scores, runs the risk of 
categorizing participants into homogenous categories when they in fact may be more 
heterogeneous, leading to a loss in power (Cohen ,1983). Hence, methodological issues may 
have prevented us from fully understanding the relationship between these variables. 
Limitations 
This study has several limitations. First is the small sample size, which increased the 
possibility of the Type II error (not finding significant differences when they in fact exist) and 
lowered the power of all analyses. The sample used in the study comprised of adolescents mostly 
of Hispanic origin, who exhibited only subthreshold symptoms. Thus, results from this study 
cannot be generalized to the community at large; rather, they should be used to develop a 
preliminary understanding of what trends in symptom improvement of subclinical depression 




Second, this study relied heavily on a single self-report measure and did not incorporate 
clinician ratings or collateral information from parents, caregivers or teachers to corroborate 
adolescent symptom ratings and improve the validity of the data. As with any self-report data, it 
is quite possible that there is a discrepancy between what the subjects are stating and what they 
are actually experiencing.  Hence, the checklist used in this study relies on the level of accuracy 
and honesty demonstrated by the adolescent in completing the measure.   
The depression symptom checklist has also not been validated for use with clinical 
populations, nor does it capture all depression symptoms.  Perhaps a more refined instrument that 
touches more specifically on every depressive symptom is required to better assess levels of 
symptom improvement in this sample.  Additionally, although changes in appetite and energy 
levels were included in the checklist, other indicators of vegetative symptoms such as changes in 
weight or lethargy were not assessed.  Similarly, additional items to study motivation could have 
been added and other categories such as cognitive or attention variables could have also been 
included to study their relative contribution to trends in the analyses.  
Another factor problematic to the data analysis of the study was the limited sample size 
and the presence of missing data. Although time points were created (each inclusive of two 
weeks) in order to work with the missing data, this lead to inconsistencies in analyzing and 
reporting results, with some analysis incorporating time points, whereas other using weeks. 
Conclusions 
This study was the first of its kind to explore the temporal relationship in symptoms as 
they improve following treatment for depression in adolescents.  Specifically, symptoms as 
classified as mood/motivation and vegetative, were explored in details with regards to their 




Taking the above limitations into account, this study found strong evidence that 
mood/motivation symptoms improve faster than vegetative symptoms for adolescents who 
present with subthreshold depression and received the preventive IPT-AST treatment. In 
addition, mood symptoms were also found to respond more to the IPT-AST treatment condition 
than vegetative symptoms. Hence, IPT-AST may be a strong option when considering a referral 
for an adolescent who presents with more mood/motivation symptoms or as an adjunct treatment 
when vegetative symptoms are responding to pharmacotherapy. In addition, adolescents should 
be monitored for their response to the IPT-AST preventive treatment. If improvements in mood 
symptoms don’t occur, it is unlikely that vegetative symptoms would improve and perhaps other 
treatment options may then need to be considered. 
Clinical Implications 
 The results from this dissertation have significant implications for the mental health 
community at large, as well as for caregivers including parents and teachers who may refer their 
child or student to receiving IPT-AST treatment for subthreshold depression. Mood and 
vegetative symptoms have different trajectories towards improvement with certain clusters of 
symptoms improving faster than others. Hence, prior to considering appropriate referrals for 
treatment, clinicians should assess for severity of mood symptoms and vegetative symptoms 
when adolescents present with depression, and be cognizant about risks associated with 
adolescents who have more mood symptoms and low vegetative symptoms.  
 Second, given the pattern of symptom change for IPT-AST preventive treatment tends to 
be similar to trends found in symptom improvement following response to cognitive therapy 
(Rush et al, 1982) with IPT-AST producing most rapid changes in mood symptom improvement 




mood symptoms are being targeted for early improvement. However, clinicians would also need 
to be aware of the potential time-lag in symptoms as they improve (with adolescents being 
referred to, or already in treatment with IPT-AST) where despite reporting continued symptoms 
in the vegetative cluster (with improved mood symptoms), there may still be a possibility for 
improvement and the potential of responding to treatment.   
Future Directions 
Future research should make use of larger, more generalizable samples obtained from 
school but also from the medical community including community clinics and other out-patient 
services. Studies should aim to recruit subjects from varying ethnicities and socioeconomic 
backgrounds, as trends may vary between different demographic or ethnic groups.   
In addition, weekly self-report measures should be balanced with other assessments that 
include clinician ratings to track any observable changes in mood, motivation, or physical 
activity of the participants. Collecting information from in-person interviews supplemented with 
information from caregivers, parents or other informants could further elaborate on the timeline 
in symptom abatement and further our understanding of how and when symptoms improve.  
One main issue encountered in this study was the lack of clarity or consistency with 
regards to the clustering of variables in the literature reviewed. Some studies researched affective 
symptoms separately, others combined symptoms into specific clusters without providing further 
details regarding those symptoms. Hence, further studies need to more carefully operationalize 
the categorization of various depression symptoms, and possibly also include other categories 
such as cognitive symptoms and suicidal symptoms, to better understand the complex 




Additionally, as a post-hoc analysis that could not compare differences in rate of 
improvement between groups, only one group could be the focus of study (based on their 
completing the depression checklist).  The ability to compare findings of trends within the IPT-
AST preventive treatment to a control group or TAU group would have added to the robustness 
of our conclusions, hence future studies should include a control group or other treatment group 
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Demographic and Sample Characteristics of Young, Mufson & Gallop (2010) Study  
 IPT-AST 
(N = 36) 
SC 
(N = 21) 
p value 
Demographics    
    Age, mean (SD) 14.57 (0.68) 14.52 (0.87) 0.84 
    Female (%) 20 (55.56) 14  (66.67) 0.41 
    Hispanic (%) 25 (69.44) 17 (80.95) 0.34 
    African American (%) 15 (41.67) 7 (33.33) 0.53 
Baseline Measures    
    CES-D, mean (SD) 26.56 (6.72) 26.05 (5.86) 0.69 
    CGAS, mean (SD) 70.75 (4.12) 70.10  (6.11) 0.55 
    CDRS-R, mean (SD) 51.75 (11.17) 48.43 (5.67) 0.25 
Current Diagnoses    
    No diagnosis (%) 29 (80.56) 18 (85.71) 0.73 
    DD NOS (%)  1 (2.78) 1 (4.76) 1.00 
    Adjustment (%) 2 (5.56) 1 (4.76) 1.00 
    GAD (%) 1 (2.78) 0 (0.00) 1.00 
    Specific Phobia (%)  2 (5.56) 1 (4.76) 1.00 
    Tic Disorder (%) 1 (2.78) 0 (0.00) 1.00 
 








Symptoms of Depression Checklist 
During the past week… 
 
1. Have you felt sad a lot?                   Yes Sometimes No 
2. Have you felt hopeless that things will never get better? Yes Sometimes No 
3. Have you gotten mad easily, sometimes over little things? Yes Sometimes No 
4. Has it been difficult to have fun doing things you used to 
enjoy? 
Yes Sometimes No 
5. Have you felt guilty about things that may not be your 
fault?          
Yes Sometimes No 
6. Have you felt more or less hungry than you used to?      Yes Sometimes No 
7. Have you had trouble falling asleep or staying asleep?        Yes Sometimes No 
8. Have you taken lots of naps or felt like sleeping all the 
time?     
Yes Sometimes No 
9. Have you had less energy than you used to?      Yes Sometimes No 
10. Have you felt bad about yourself?  Yes Sometimes No 
11. Has it been difficult to pay attention in school?                               Yes Sometimes No 
12. Has it been hard to make decisions?                                             Yes Sometimes No 
13. Have you had headaches or stomachaches a lot?       Yes Sometimes No 
14. Have you wished you weren’t born or you could just 
disappear?     
Yes Sometimes No 





RATE YOURSELF ON A SCALE OF 1-10, WHERE 1 IS THE BEST YOU’VE EVER FELT 
AND 10 IS THE MOST DEPRESSED YOU’VE EVER FELT. 
 
----------------------------------------------------------------------------------------------------- 























Screen letters sent 
n = 1117 
Parent refused 
n = 346 
Teen refused 
n = 125 
Teen absent 
n = 4 
Screened with CES-D 
n = 642 
Normal CES-D 
CES-D< 15 





n = 235 + 2 
 
 
CES-D too high 
CES-D>40 




Consented to diagnostic 
interview 




n = 21 
Left school 
n = 1 
Eligible 
n = 57 
 
IPT-AST 




n = 21 
Refused to Consent to 
diagnostic interview 
n = 158 
 
 
